Home
  >  
Section 36

EurekaMag Full Text Articles Chapter 35,974



References:

Yoshimatsu, K.; Shimomura, K.; Yamazaki, M.; Saito, K.; Kiuchi, F. 2003: Transformation of ipecac with Agrobacterium rhizogenes. Planta Medica 69(11): 1018-1023
Krawetz, J.E.; Jobin, C.; Wang, X.C.; Jaffe, G.J.; Allen, J.B. 1999: Transformation of iris/ciliary body cells with an adenoviral vector expressing an IkappaB mutant. IOVS Investigative Ophthalmology and Visual Science 40(4): S138
YangJianJun; HuShaoPing; ChenXinCai; YuMingGe; LiuJin; LiHang; ShenChaoFeng; ShiJiYan; ChenYingXu 2010: Transformation of lead solid fraction in the rhizosphere of Elsholtzia splendens the importance of organic matter. Water, Air, And Soil Pollution 5: 1 4, 333-342
Destefano, A.L.; Benjamin, E.J.; Larson, M.L.; O'donnell, C.J.; Vasan, R.S.; Cupples, L.A.; Myers, R.H.; Levy, D. 2000: Transformation of left ventricular phenotypes in a genome scan in the NHLBIs Framingham Heart Study. Genetic Epidemiology 19(3): 245-246
Xie, Z.; Zeng, X.; Clark, J.H.; Haridasse, V.; Glazer, R.I. 2003: Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 is associated with increased c-myc expression and downregulation of caveolin-1. Proceedings of the American Association for Cancer Research 44: 1244
Mustacich, D.J.; Coon, A.E.; Powis, G. 2001: Transformation of mouse NIH/3T3 cells by nuclear targeted thioredoxin-1 and the role of the three major MAP kinase cascades. Free Radical Biology and Medicine 31(10): S140
Hasni, K.; Gunnala, V.; Shah, M.; Hoang, T.; Kung, S.C.; Brodsky, I.; Kumar, M.A.; Heifets, M. 2003: Transformation of myelodysplastic syndrome to hypocellular Acute Myeloid Leukemia post renal transplant. Journal of the American Society of Nephrology 14(Abstracts Issue): 923A
Zablotowicz, R.M.; Hoagland, R.E.; Lee, H.; Trevors, J.T.; Hall, J.C.; Locke, M.A. 1999: Transformation of nitroaromatic herbicides and related xenobiotics by microorganisms and plants. Abstracts of Papers American Chemical Society 218(1-2): AGRO 167
Mei, J.; Fecteau, K.A.; Wang, H.C.ain R. 2002: Transformation of noncancerous human breast epithelial MCF10A by the tobacco-specific carcinogen NNK. Proceedings of the American Association for Cancer Research 43: 4
Nascimento, L.C.; Assis Filho, F.M.; Paguio, O.R.; Deom, C.M.; Sherwood, J.L. 2003: Transformation of peanut with the tomato spotted wilt virus non-structural gene from the S RNA. Phytopathology 93(6 Suppl): S64-S65
Park, J.W.; Kim, J.E. 2000: Transformation of pentachlorophenol through oxidative coupling. Abstracts of Papers American Chemical Society 220(Part 1): AGRO 123
Li, X.; Veronese, P.; Niu, X.M.; Koiwa, H.; Quintero, J.; Zhu, X.; Ruggeiro, B.; Bressan, R.; Hasegawa, P.; Weller, S. 1999: Transformation of peppermint and evaluation of herbicide resistance in transgenic plants. Plant Biology (Rockville) : 100
Anabousi, S.; Shervington, A. 2000: Transformation of plant cells with DNA encoding antibiotic resistance. Biochemical Society Transactions 28(5): A208
Davidson, M.M.; Takla, M.F.G.; Jacobs, J.M.E.; Butler, R.C.; Wratten, S.D.; Conner, A.J. 2004: Transformation of potato cultivars with a cry1Ac9 gene confers resistance to potato tuber moth. New Zealand Journal of Crop and Horticultural Science 32(1): 39-50
Berska, J.; Mysliwa Kurdziel, B.; Latowski, D.; Strzalka, K. 2001: Transformation of protochlorophyllide to chlorophyllide and carotenoid contents in wheat under heavy metal stress. Acta Physiologiae Plantarum 23(3 Suppl): 34
Berska, J.; Mysliwa Kurdziel, B.; Strzalka, K. 2001: Transformation of protochlorophyllide to chlorophyllide in wheat under heavy metal stress. Photosynthesis Research 69(1-3): 20
Tian, Y.C.; Evans, R.A.; Phillips, A.O. 2001: Transformation of proximal tubular epithelial cells does not equate with transdifferentiation. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 694A
Oganesyan, E.T.; Pyshchev, A.I.; Butenko, L.I. 2000: Transformation of pyrylium acetates into benzene derivatives. Khimiko-Farmatsevticheskii Zhurnal 34(2): 49-50
Maltby, J.D.; Clements, S.; Mann, D.A.; Sheron, N. 1999: Transformation of rat hepatic stellate cells to a myofibroblastic phenotype in vitro is associated with evidence of activation of a STAT DNA binding protein. Hepatology 30(4 Part 2): 494A
Grupp, C.; Troche Polzien, I.; Avci, Y.; Kohler, M.; Mahrt, J.; Muller, G.A. 2001: Transformation of renal fibroblasts to myofibroblasts Modulation by tubuloepithelial cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 703A
Phan, B.H.; Topp, C.; Zhong, C.; Akoh, U.; Jiang, J.; Dawe, R.K.; Parrott, W.A. 2003: Transformation of rice with bacterial artificial chromosome DNA. In Vitro Cellular and Developmental Biology. Plant 39: 44A
Schaaf, O.; Dettner, K. 2000: Transformation of steroids by Bacillus strains isolated from the foregut of water beetles II Metabolism of 3beta-hydroxypregn-5-en-20-one. Journal of Steroid Biochemistry and Molecular Biology 75(2-3): 187-199, 15 December
Wawrzynczak, D.; Sowik, I.; Michalczuk, L. 1999: Transformation of strawberry with IAA-glucose synthetase gene. Biologia Plantarum 42(Suppl ): S26
Kuykendall, L.D.; Stockett, T.M.; Saunders, J.W. 2002: Transformation of sugar beet with a Cercosporin export gene, cfp. Phytopathology 92(6 Suppl): S43
Mccormick, M.L.; Adriaens, P. 2000: Transformation of tetrachloromethane in a defined iron-reducing culture Relative contributions of cell and mineral mediated reactions. Abstracts of Papers American Chemical Society 219(1-2): Envr 13
Knoke, K.L.; Noguera, D.R.; Fox, B.G.; Chambliss, G.H. 1999: Transformation of the explosive 2,4,6-trinitrotoluene by a purified enzyme from Pseudomonas fluorescens isolated from contaminated soil. Abstracts of the General Meeting of the American Society for Microbiology 99: 583
Grossman, A.R.; Kehoe, D.M. 2000: Transformation of the filamentous cyanobacterium Fremyella diplosiphon. Eynard, Natalie, Teissie, Justin Springer Lab Manuals Electroformation of bacteria 235-241
Lawrence, G.J.; Dodds, P.N.; Ellis, J.G. 2010: Transformation of the flax rust fungus, Melampsora lini: selection via silencing of an avirulence gene. Plant Journal: for Cell and Molecular Biology 61(2): 364-369
Mcmahon, M.B.; Yourman, L.F.; Caesar, A.J.; Luster, D.G. 2001: Transformation of the leafy spurge pathogen Fusarium oxysporum for expression of green fluorescent protein. Phytopathology 91(6 Suppl): S61
Jasinoski, S.J. 2003: Transformation of the theropod scapulocoracoid using thin-plate splines. SICB Annual Meeting and Exhibition Final Program and Abstracts : 203
Saparrat, M.C.N.; Jurado, M.; Díaz, R.; Romera, I.Garcia.; Martínez, Mía.Jesús. 2010: Transformation of the water soluble fraction from "alpeorujo" by Coriolopsis rigida: the role of laccase in the process and its impact on Azospirillum brasiliense survival. Chemosphere 78(1): 72-76
Hunn, B.C.; Wright, M.S.; Cary, J.W.; Rajasekaran, K.; Timpte, C.S. 1999: Transformation of tobacco and cotton with a grapevine stilbene synthase gene to confer enhanced resistance to fungal pathogens. Abstracts of the General Meeting of the American Society for Microbiology 99: 498
Krizkova, L.; Elckner, M.; Petrasek, J.; Zazimalova, E. 2001: Transformation of tobacco cell suspension culture VBI-0 via Agrobacterium carrying phytohormone-related genes. Chromosome Research 9(Suppl 1): 151
Mazurova, L'ubica; Subr, Z.; Glasa, M.; Kudela, O. 1999: Transformation of tobacco plants with the alfalfa mosaic virus T6 coat protein and human alpha 2 interferon genes in sense and antisense orientation. Biologia 54(Suppl 7): 46
Lopez Meyer, M.; Gaxiola Urias, M.; Perea Araujo, L. 2002: Transformation of tomato cultivar Micro-Tom by infiltration of flowers and seedlings with Agrobacterium. Plant Biology (Rockville) : 184
Liyanapatirana,C.; Gwaltney,S.R.; Xia,K. 2010: Transformation of triclosan by Fe -saturated montmorillonite. Environmental Science and Technology: 2, 668-674
Tankovich, N. 1999: Transformation of unwanted tissue by deep laser heating of water. Official Gazette of the United States Patent and Trademark Office Patents 1221(4)
Rao Akireddy, S.; Adamczyk, M.; Reddy, R.E. 2000: Transformation of vitamin B6 to -Deoxypyridinoline, a useful biochemical marker for diagnosis of osteoporosis. Abstracts of Papers American Chemical Society 219(1-2): ORGN 714
Adamczyk, M.; Akireddy, S.R.; Reddy, R.E. 2000: Transformation of vitamin B6 to -deoxypyridinoline, a useful biochemical marker for diagnosis of bone diseases. Tetrahedron 56(16): 2379-2390
Cass, D.D.; Mcgann, L.E.; Zhang, G.; Laurie, J.D.; Ranch, J.P.; Gordon Kamm, W.J. 2001: Transformation of zygote, egg or sperm cells and recovery of transformed plants from isolated embryo sacs. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)
Golobic,M. 2010: Transformation processes of alpine landscapes and policy responses top-down and bottom-up views. Society and Natural Resources: 3, 269-280
Van Zelm, R.; Huijbregts, M.A.J.; van de Meent, D. 2010: Transformation products in the life cycle impact assessment of chemicals. Environmental Science and Technology 44(3): 1004-1009
Tan, C.L.; Davey, M.R.; Lowe, K.C.; Power, J.B. 1999: Transformation studies in Theobroma cacao. Journal of Experimental Botany 50(Suppl ): 20-21
Emalfrab, M.A.; Burlingame, R.P.; Olson, P.T.; Sinitsyn, A.P.; Parriche, M.; Bousson, J.C.; Pynnonen, C.M.; Punt, P.J.; Van Zeijl, C.M. Johanna 2003: Transformation system in the field of filamentous fungal hosts. Official Gazette of the United States Patent and Trademark Office Patents 1271(1)
Shewmaker, C.K.; Facciotti, D.G. 2003: Transformation system with Ti or Ri plasmid. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)
D'Enfert, C.; Weidner, G.; Mol, P.C.; Brakhage, A.A. 1999: Transformation systems of Aspergillus fumigatus. new tools to investigate fungal virulence. Contributions to Microbiology 2: 149-166
Liu, J.; Patterson, A.; Thompson, J.A.; Mills, G.; Bast, R.C.J. 2003: Transformation targets of human ovarian surface epithelial cells by oncogenic H-rasV12 or K-rasV12 revealed by gene expression array. Proceedings of the American Association for Cancer Research 44: 234-235
Kearney, P.P.; Boutros, R.; Dodds, A.J.; Biggs, J.C. 2001: Transformation to acute leukaemia in an MDS patient harbouring bcr-abl and bcl 2-IgH rearrangements, without expression of either activated oncogene. Leukemia Research 25(4): 359-360
Parrott, W.A.; Thomson, J.M.chael 2000: Transformation vector system. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)
D.G., H.M. Jozef; Salgado, M.B. Leonor, F. Van Montagu, M.C. Ernest; Vaeck, M.A.; Zabeau, M.F. Oscar; Leemans, J.J. August; Hofte, H.F. Paulus 2000: Transformation vectors allowing expression of truncated BT2 endotoxins in plants. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)
Heinen, P.; Nitz, I.; Puzio, P.S.; Golinowski, W.; Sobczak, M.; Ohl, S.; Grundler, F.M.W. 2000: Transformation with Agrobacterium rhizogenes induces nematode resistance in Raphanus sativus roots. Nematology 2(7): 761
Resnick, M.A.; Larionov, V.L.; Kouprina, N.Y.; Perkins, E.L. 2002: Transformation-associated recombination cloning. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)
Ross, M.C.; Church, L.A.; Gordon Kamm, W.J. 2002: Transformation-enhancing compositions and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1262(1)
Hsu, T.C.; Li, J.J.; Young, M.; Zhang, S.N.; Nair, R.; Hegamyer, G.; Colburn, N.H. 1999: Transformation-resistant mouse JB6 cells owe their resistance in part to lack of NF-kappaB activation. Proceedings of the American Association for Cancer Research 40: 375
Hui Sheng Ai; Cun Hua Zao; Guo Mei; Chang Lin Yu; Dan Hong Wang; Jian Hui Qiao; Qi Yun Sun; Wan Jun Sun; Zhang Shi 2003: Transformations and clinical importances of hematopoietic chimerism in nonmyeloablative allogeneic stem cell transplantation. Experimental Hematology (New York) 31(7 Suppl 1): 111
Ganley, K.J.; Bradley, N.S. 1999: Transformations in embryonic motility in chick E9 to E18. Society for Neuroscience Abstracts 25(1-2): 2177
Banski,J.; Wesoowska,M. 2010: Transformations in housing construction in rural areas of Polands Lublin region - influence on the spatial settlement structure and landscape aesthetics. Landscape And Urban Planning: 2, 116-126
Majorova, H.; Rocek, Z. 2004: Transformations of aortic arches during metamorphosis of the spade-foot toad, Pelobates fuscus. Journal of Morphology 260(3): 309
Meade, J.D.; Hellou, J.; Patel, T. 2001: Transformations of sulfur, nitrogen, and oxygen heterocycles by three marine bacterial consortia. Abstracts of Papers American Chemical Society 221(1-2): ENVR 242
Nicolaou, K.C.; Nantermet, P.G.; Guy, R.K.; Ueno, H. 2000: Transformations of taxol. Official Gazette of the United States Patent and Trademark Office Patents 1232(4)
Gendron, S. 2001: Transformative alliance between qualitative and quantitative approaches in health promotion research. Who Regional Publications. European Series 92: 107-121
Fouly, H.M.; Henning, S.; Park, J.; Wilkinson, H.T. 2003: Transformed Gaeumannomyces graminis var tritici expressing hygromycin resistance and disrupted melanin production. Phytopathology 93(6 Suppl): S27
Clare, J.J.; Romanos, M.A. 2001: Transformed Pichia expressing the pertactin antigen. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)
Gallaher, B.W.; Berthold, A.; Klammt, J.; Kratzsch, J.; Kiess, W. 1999: Transformed and non-transformed cell lines exhibit divergent patterns of gene expression following induction of apoptosis by colcemid treatment. Growth Hormone and IGF Research 9(5): 339
Vladimirov, A.; Nijjer, S.; Roberts, P.J. 2002: Transformed astrocytes are vulnerable to AMPA- and kainate-induced excitotoxic injury. British Journal of Pharmacology 135(Proceedings Suppl): 107P
Bauer, G. 2002: Transformed cell-derived reactive oxygen species drive efficiency and selectivity of natural antitumor systems. International Journal of Molecular Medicine 10(Suppl 1): S51
Borovsky, D. 2003: Transformed cells useful for the control of pests. Official Gazette of the United States Patent and Trademark Office Patents 1270(2)
Rangan, T.S.; Anderson, D.M.; Rajasekaran, K.; Grula, J.W.; Hudspeth, R.L.; Yenofsky, R.L. 2003: Transformed cotton plants. Official Gazette of the United States Patent and Trademark Office Patents 1277(2)
Dormann, M.; Wang, H.M.; Oelck, M. 2001: Transformed embryogenic microspores for the generation of fertile homozygous plants. Official Gazette of the United States Patent and Trademark Office Patents 1252(2)
Cooper, R.K.; Enright, F.M. 2000: Transformed eukaryotic cells. Official Gazette of the United States Patent and Trademark Office Patents 1241(1)
Buttar, N.; Wang, K.; Smyrk, T.; Pacifico, R.; Song, L.M.chel Wong Kee; Lutzke, L.; Andersen, M.; Gao, T. 2002: Transformed fibroblasts and progression of neoplasia in Barretts esophagus. Gastroenterology 122(4 Suppl 1): A57-A58
Selten, G.C. Mari; Swinkels, B.W.; Van Gorcom, R.F. Maria 2000: Transformed fungal strains free of selection marker. Official Gazette of the United States Patent and Trademark Office Patents 1234(3)
Sanders, J.P. Marinus; Van Den Berg, J.A.; Andreoli, P.M.; Vos, Y.J.; Van Ee, J.H.; Mulleners, L.J.S.M. 2000: Transformed industrial bacillus strains and methods for making and using them. Official Gazette of the United States Patent and Trademark Office Patents 1236(1)
Kenten, J.H.; Boss, M.A. 1999: Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)
Donovan, W.P.; Tan, Y.; Jany, C.S.; Gonzalez, J.M. 1999: Transformed plant with Bacillus thuringiensis toxin gene. Official Gazette of the United States Patent and Trademark Office Patents 1225(4)
Broekaert, W.F.; Cammue, B.P. Angelo; Osborn, R.W.; Rees, S.B. 1999: Transformed plants expressing antimicrobial proteins. Official Gazette of the United States Patent and Trademark Office Patents 1224(1)
Vasil, I.K.; Vasil, V. 2001: Transformed wheat having improved breadmaking characteristics. Official Gazette of the United States Patent and Trademark Office Patents 1247(4)
Klaassen, P.; Van Rooijen, R.J.n 2000: Transformed yeast strains. Official Gazette of the United States Patent and Trademark Office Patents 1241(2)
Silvian, S. 2002: Transformer assembly for implantable cardiac stimulation device. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)
Kashyap, M.; Ryan, J. 2004: Transforming Growth Factor Beta-1 Inhibits Fc Epsilon RI Expression and Granulation in Mouse Mast Cells. FASEB Journal 18(4-5): Abstract 552
Porta, N.F.M.; Mata Greenwood, E.; Fineman, J.R.; Black, S.M. 2001: Transforming Growth Factor beta-1 increases Vascular Endothelial Growth Factor through reactive oxygen intermediates. Pediatric Research 49(4 Part 2): 300A
Ahmadzadeh, M.; Rosenberg, S.A. 2004: Transforming Growth Factor- beta 1 attenuates the differentiation and effector function of tumor antigen specific human memory CD8 T cells. FASEB Journal 18(4-5): Abstract 775
Ostroukhova, M.V.; Seguin Devaux, C.; Oriss, T.B.; Dixon Mccarthy, B.; Ray, A. 2004: Transforming Growth Factor- beta and Notch Contribute to Airway Tolerance in Mice. FASEB Journal 18(4-5): Abstract 91
Langer, J.C.; Henckaerts, E.; Cereseto, A.; Snoeck, H.W.llem 2002: Transforming Growth Factor-Beta2 Is a Positive Regulator of Hematopoiesis Subject to Age-Related and Quantitative Genetic Variation. Blood 100(11): Abstract No. 2822
Gingery, A.; Gorny, G.A.; Oursler, M.J. 2002: Transforming Growth Factor-beta induced osteoclasts survive by activating divergent survival pathways. Journal of Bone and Mineral Research 17(Suppl 1): S456
Bartolome, Javier; De Lucas, Susana; Carreno, Vicente 2002: Transforming Growth Factor-beta induces the degradation of the Hepatic Nuclear Factor-4 in the proteasome. Hepatology 36(4 Part 2): 240A
Masszi, A.; Kapus, A.; Rosivall, L.; Mucsi, I. 2002: Transforming Growth Factor-beta regulates beta-catenin dependent gene expression during epithelial mesenchymal transformation. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 204
Shah, A.H.; Tabayoyong, W.B.; Lee, C. 2002: Transforming Growth Factor-beta signaling in leukocytes is a viable target for retroviral gene therapy in highly aggressive murine melanoma model. Proceedings of the American Association for Cancer Research 43: 594
Oz, H.S.; Dryden, G.W.; Ray, M.B.; Chen, T.S.; Mcclain, C.J. 2002: Transforming Growth Factorbeta2 containing enteral formula attenuates enterocolitis in Interleukin-10 deficient mice. Gastroenterology 122(4 Suppl 1): A-397
Hamada, K. 2002: Transforming RNA Creation of a cellular condition prerequisite for malignant transformation. International Journal of Molecular Medicine 10(Suppl 1): S47
Garriga Canut, M.; Orkin, S.H. 2004: Transforming acidic coiled-coil protein 3 controls friend of GATA-1 subcellular localization and regulates the association between GATA-1 and FOG-1 during hematopoiesis. Journal of Biological Chemistry 279(22): 23597-23605
Maeda, T.; Yagasaki, F.; Ishikawa, M.; Wakao, D.; Takahashi, N.; Itoh, Y.; Kawai, N.; Matsuda, A.; Bessho, M. 2003: Transforming activity and specific inhibition of TEL-FGFR3 fusion protein in a patient with peripheral T-cell lymphoma, which subsequently progressed to acute myelogenous leukemia with myeloproliferative disease. Blood 102(11): 583a
Chakravarti, D.; Mailander, P.; Cavalieri, E.; Rogan, E. 2000: Transforming and non-transforming mutations in dibenzo pyrene-initiated and TPA-promoted papillomas. Proceedings of the American Association for Cancer Research 41: 570
Corbella, S. 2000: Transforming aspects of group work for patients with personality disorders. European Psychiatry 15(Suppl 1): 63
George, Y.S.; Musante, S.; Biosciednet Coordinating Council 2002: Transforming biology teaching and learning in higher education institutions through online resources. FASEB Journal 16(5): A741
Fivizzani, K.P. 2003: Transforming employees into safety partners. Abstracts of Papers American Chemical Society 226(1-2): CHAS 2
Rassool, F.V.; Mufti, G.J. 1999: Transforming events in myelodysplastic syndromes. Leukemia Research 23(Suppl 1): S23
Lijnen, P.; Fagard, R.; Petrov, V. 1999: Transforming factor-beta-induced collagen synthesis during calcium channel blockade in cardiac fibroblasts. European Journal of Clinical Investigation 29(Suppl 1): 12
Muralidhar, S.; Rosenthal, L.J. 2001: Transforming genes of human cytomegalovirus and human herpesvirus 6. Rosenthal, Leonard J Monographs in Virology Mechanisms of DNA tumor virus transformation 88-106
Rosenthal, L.J.; Muralidhar, S. 2001: Transforming genes of human herpesvirus 8. Rosenthal, Leonard J Monographs in Virology Mechanisms of DNA tumor virus transformation 107-119
Donaldson, P.T.; Clare, M.C.; Craig, W.L.; Hudson, M.; Harrison, P.; Jones, D.E.; Bassendine, M.F.; James, O.F. 2000: Transforming growth cell factor beta-1 gene polymorphisms in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 32(4 Pt 2): 174A
Aharinejad, S.; Abraham, D.; Schafer, R.; Grimm, M. 2004: Transforming growth factor - beta 1 and basic fibroblast growth factor specifically regulate factors mediating cardiac extracellular matrix remodeling in dilated cardiomyopathy. FASEB Journal 18(4-5): Abstract 734
Segal, J.H.; Phan, S.H.; Wiggins, R.C.; Weitzel, W.F. 2002: Transforming growth factor -beta release induced by hemodialysis vascular access. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 407A
Tamaki, K.; Tamai, O.; Fujisawa, M.; Itoh, S.; Kawachi, H.; Shimizu, F.; Imaizumi, T.; Heldin, C.H.; Ten Dijke, P.; Okuda, S. 1999: Transforming growth factor -beta1 induced phosphorylation of Smad2 in mesangial cells in vitro and in vivo. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 581A
Feinberg, M.W.; Jain, M.K.; Werner, F.; Sibinga, N.E.S.; Wiesel, P.; Perrella, M.A.; Lee, M.E. 2000: Transforming growth factor -beta1 inhibits human metalloelastase through an activating protein -1 dependent, SMAD3 signaling pathway. Circulation 102(18): 2; 299
Akiyama, Y.; Wiltrout, R.H.; Ruscetti, F.W. 1999: Transforming growth factor -beta1 promotes the mobilization of dendritic cells to lymphoid organs induced by Flt-3 ligand in vivo. Proceedings of the American Association for Cancer Research 40: 656
Alonzo, E.J.; Bellorin Font, E.; Weisinger, J.R.; Arciniegas, E.; Carlini, R.G. 2000: Transforming growth factor B down regulates the erythropoietin receptor expression in endothelial cells but does not alter his function. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 255A
Moiseeva, O.M.; Villevalde, S.V.; Lyasnikova, E.A.; Semenova, E.G.; Shlyachto, E.V. 2003: Transforming growth factor B-1 and activation leukocyte in patients with essential hypertension. European Heart Journal 24(Abstract Suppl): 6
Rivera, M.A.; Gagnon, J.; Rice, T.; Simoneau, J.A.; Perusse, L.; Leon, A.S.; Skinner, J.S.; Wilmore, J.H.; Rao, D.C.; Bouchard, C. 1999: Transforming growth factor B1 gene polymorphism and blood pressure response to acute exercise in the heritage family study. Medicine and Science in Sports and Exercise 31(5 Suppl): S373
Wei, Y.F.; Meissner, P.S.; Ni, J. 2002: Transforming growth factor alpha HII. Official Gazette of the United States Patent and Trademark Office Patents 1259(4)
Wadgaonkar, P.S.; Carney, K.; Swartz, D.D.; Nickerson, P.A.; Nielsen, L.C.; Wang, H.; Huyck, H.L.; Metlay, L.A.; Pryhuber, G.S.; Ryan, R.M. 2002: Transforming growth factor alpha expression in human newborn acute and chronic lung injury. Pediatric Research 51(4 Part 2): 350A
Cabrijan, L.; Zamolo, G.; Stifter, S.; Kastelan, M.; Palle, M.; Gruber, F. 2001: Transforming growth factor alpha immunostaining in keratoacanthoma and squamous cell carcinoma of the skin. Virchows Archiv 439(3): 367
Waheed, S.Z.; D'angio, C.T.; Madtes, D.K.; Finkelstein, J.N.; Paxhia, A.; Ryan, R.M. 1999: Transforming growth factor alpha is not necessary for keratinocyte growth factor induced in vivo type II cell proliferation. Pediatric Research 45(4 Part 2): 325A
Ren, J.; Xia, Y.; Mesiya, S.; Harty, R.F. 1999: Transforming growth factor alpha mediation of gastric protection involves capsaicin-sensitive afferent neurons. Gastroenterology 116(4 Part 2): A182
Meissner, P.S.; Fuldner, R.A.; Fei Wei, Y.; Adams, M.D. 2000: Transforming growth factor alphaHI. Official Gazette of the United States Patent and Trademark Office Patents 1235(2)
Pucci, M.L.; Schuster, V.L. 1999: Transforming growth factor and indomethacin increase the expression of the prostaglandin transporter PGT in cultured rat fibroblasts. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 56A-57A
You, R.; Pappas, P.J.; Hobson, R.W.II.; Duran, W.N. 1999: Transforming growth factor beta 1 , matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 gene expressions in varicose veins. FASEB Journal 13(4 Part 1): A8
Lagranha, C.J.; Doi, S.Q.; Pithon Curi, T.C.; Suzuki, K.; Kohn, L.D.; Sellitti, D.F. 2002: Transforming growth factor beta 1 -like activity of thyroglobulin in mouse mesangial cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 77A-78A
Zdarska, D.; Kvapil, M.; Zavadova, E. 2003: Transforming growth factor beta 1 in plasma of patients with newly diagnosed diabetes mellitus Type 2 in comparison to patients with latent autoimmune diabetes mellitus. Diabetes and Metabolism 29(Hors serie 2): 4S87-4S88
Seghezzi, G.; Pintucci, G.; Yun, J.; Steinberg, B.M.; Ferdinand, B.; Grossi, E.A.; Baumann, F.G.; Colvin, S.B.; Galloway, A.C.; Mignatti, P. 2000: Transforming growth factor beta 1 induces a growth factor cascade that results in extracellular-regulated kinase and p38 mitogen-activated protein kinase activation in endothelial cells. Journal of the American College of Cardiology 35(2 Suppl A): 296A
Forino, M.; Murer, L.; Dalla Vella, M.; Graziotto, R.; Gambaro, G.; Favaro, S.; Anglani, F. 2001: Transforming growth factor beta 1 induces epithelial-mesenchymal transdifferentiation but not myofibroblast transition in human epithelial tubular cells. Nephrology Dialysis Transplantation 16(6): A18
Black, D.; Lyman, S.; Qian, T.; Lemasters, J.J.; Rippe, R.; Behrns, K.E. 2003: Transforming growth factor beta 1-induced hepatocyte apoptosis is mediated by Smad3-dependent acute generation of reactive oxygen species. Hepatology 38(4 Suppl 1): 565A
Marchionni, C.; Tonelli, R.; Pierdomenico, L.; Ghinassi, B.; Fossati, V.; Alviano, F.; Bonsi, L.; Bagnara, G.; Paolucci, G. 2003: Transforming growth factor beta 2 gene structure and mutational screening in patients with congenital thrombocytopaenia with absent radii. Experimental Hematology (New York) 31(7 Suppl 1): 72-73
Romitti, P.A.; Lidral, A.C.; Murray, J.C.; Daack Hirsch, S.; Burns, T.L. 2000: Transforming growth factor beta 3 and orofacial clefts. Teratology 61(6): 450
Coerper, S.; Ziftel, T.T.; Wolf, W.; Cox, D.; Jehle, E.C.; Becker, H.D. 1999: Transforming growth factor beta 3 inhibits pentagastrin-stimulated gastric acid secretion in rats. Gastroenterology 116(4 Part 2): A368
Arnaldi, G.; Mancini, T.; Freddi, S.; Balercia, G.; Masini, A.; Mantero, F. 2000: Transforming growth factor beta Implications in adrenocortical tumorigenesis. Journal of Endocrinological Investigation 23(6 Suppl): 18
Berthoux, F.B.; Tuglular, S.S.; Mariat, C.C.; Berthoux, P.B. 2001: Transforming growth factor beta TGFB gene polymorphisms and IgA nephropathy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 66A
Heegaard, A.M.; Young, M.F.; Jensen, K. 1999: Transforming growth factor beta activation of the human biglycan promoter involves several responsive elements. Journal of Bone and Mineral Research 14(Suppl 1): S298
Aziz, T.M.; Burgess, M.I.; Hasleton, P.S.; Yonan, N.A.; Deiraniya, A.K.; Rahman, A.N.; Campbell, C.S.; Hutchinson, I.Iv 2000: Transforming growth factor beta and diastolic left ventricular dysfunction following heart transplantation Echocardiographic and histological evidence. Journal of Heart and Lung Transplantation 19(1): 55
Maisch, B.; Diepholz, D.; Funck, R.; Wilke, A.; Arnold, R. 2004: Transforming growth factor beta and factor XIIIa are constituents of the carcinoid heart endocardial layer A study by confocal laser microscopy. Journal of the American College of Cardiology 43(5 Suppl A): 188A-189A
Kolli, P.; Li, L.; Zimmermann, E.M. 2000: Transforming growth factor beta and insulin like growth factor I stimulate collagen synthesis in rat intestinal smooth muscle. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A800
Walker, R.A. 2000: Transforming growth factor beta and its receptors: their role in breast cancer. Histopathology 36(2): 178-180
Bissell, D.M.; Roulot, D.; George, J. 2001: Transforming growth factor beta and the liver. Hepatology 34(5): 859-867
Hybertson, B.M.; Cho, O.K.; Allard, J.D.; Repine, J.E. 1999: Transforming growth factor beta contributes to neutrophil-mediated lung leak in rats. FASEB Journal 13(5 Part 2): A828
Mittl, P.; Grutter, M.; Arvinte, T. 2001: Transforming growth factor beta crystals. Official Gazette of the United States Patent and Trademark Office Patents 1250(4)
Ma, L.J.; Donnert, E.; Sheppard, D.; Fogo, A.B. 2001: Transforming growth factor beta dependent and independent pathways of induction of tubulointerstitial fibrosis in alphavbeta6 -/- mice. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 819A
Harding, P.; Haney, L.B.; Brewer, G.; Glass, W.F.II 1999: Transforming growth factor beta down-regulates COX-2 expression and increases the RNA instability factor, AUF1, in human mesangial cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 547A
Miller, A.C.; Sun, J.; Dahl, M.J.; Carlton, D.P.; Bland, R.D.; Albertine, K.H. 2002: Transforming growth factor beta expression is not affected in the lungs of preterm lambs with chronic lung disease of prematurity. Journal of Investigative Medicine 50(1): 35A
Cherian, S.; Love, S.; Thoresen, M.; Whitelaw, A. 2003: Transforming growth factor beta in an animal model of post-hemorrhagic hydrocephalus. Pediatric Research 53(4 Part 2): 537A-538A
Azhar, M.; Schultz, J.E.J.; Grupp, I.; Dorn, G.W.; Meneton, P.; Molin, D.G.M.; Gittenberger-de Groot, A.C.; Doetschman, T. 2003: Transforming growth factor beta in cardiovascular development and function. Cytokine and Growth Factor Reviews 14(5): 391-407
Fitzpatrick, D.R.; Bielefeldt-Ohmann, H. 1999: Transforming growth factor beta in infectious disease: always there for the host and the pathogen. Trends in Microbiology 7(6): 232-236
Naing, S.; Kwong, K.; Literat, A.; Ramanathan, R.; Jones, C.; Minoo, P. 2002: Transforming growth factor beta in the lungs of preterm infants. Pediatric Research 51(4 Part 2): 354A
Ellenrieder, V.; Hendler, S.; Lacher, U.; Alber, B.; Adler, G.; Gress, T.M. 1999: Transforming growth factor beta induces an epithelial-mesenchymal transdifferentiation of PANC-1 cells and is associated with increased invasiveness. Gastroenterology 116(4 Part 2): A398
Masszi, A.; Terebessy, T.; Fintha, A.; Huszar, T.; Rosivall, L.; Kapus, A.; Mucsi, I. 2001: Transforming growth factor beta induces epithelial-mesenchymal transformation in renal tubular cells. Nephrology Dialysis Transplantation 16(6): A40
Wardrop, R.M.; Tridandapani, S.; Marsh, C.B. 2002: Transforming growth factor beta inhibits Fc gamma R-induced monocyte chemoattractant protein-1. FASEB Journal 16(5): A1080
Shacka, J.J.; Kim, E.S.; Roberts, A.B.; Flanders, K.C. 1999: Transforming growth factor beta is a survival factor in the oxidative stress response. Free Radical Biology and Medicine 27(Suppl 1): S142
Mocanu, M.M.; Baxter, G.F.; Yellon, D.M. 1999: Transforming growth factor beta limits infarction when administered during early reperfusion Modification of lethal reperfusion injury?. Journal of Molecular and Cellular Cardiology 31(6): A101
Schacke, W.; Hattenbach, L.O.; Beck, K.F.; Pfeilschifter, J.; Koch, F. 2000: Transforming growth factor beta modulates tissue plasminogen activator expression in human retinal glial cells. IOVS Investigative Ophthalmology and Visual Science 41(4): S850
Bayat, A.; Alansari, A.; Shah, M.; Watson, J.S.; Stanley, J.K.; Ferguson, M.W.J.; Ollier, W.E. 2001: Transforming growth factor beta one polymorphism and Dupuytrens disease. European Journal of Human Genetics 9(Suppl 1): P1304
Bischoff, S.C.; Nguyen, Q.T.; Mierke, C.; Lorentz, A.; Gebert, A.; Meliss, R.R.; Stolte Mand Manns, M.P. 1999: Transforming growth factor beta production by eosinophils in the human intestinal mucosa. Immunology Letters 69(1): 91
Grady, W.M.; Myeroff, L.L.; Rerko, R.M.; Willson, J.K.V.; Markowitz, S.D. 2001: Transforming growth factor beta receptor type II affects responsiveness of colon cancer cell lines to 5-fluorouracil. Toxicologic Pathology 29(6): 705-706
Manderson, E.N.; Mes Masson, A.M.; Provencher, D.; Tonin, P.N. 1999: Transforming growth factor beta receptor type II gene mutations within a 10-bp polyadenine repeat are rare in human epithelial ovarian cancer. Gynecologic Oncology 72(3): 480-481
Grady, W.M.; Olechnowicz, J.; Markowitz, S.; Willis, J. 1999: Transforming growth factor beta receptor type II mutations associate with increased expression of cdk4 in colon cancer. Gastroenterology 116(4 Part 2): A414
Shin, I.; Bakin, A.; Rodeck, U.; Arteaga, C.L. 2001: Transforming growth factor beta regulates forkhead transcription factors via phosphatidylinositol-3-Kinase -Akt signaling. Proceedings of the American Association for Cancer Research 42: 524
Mathew, B.S.; Kesari, A.L.; Chellam, V.G.; Nair, M.K.; Pillai, M.R. 2000: Transforming growth factor beta related to extent of tumor angiogenesis but not apoptosis or proliferation in breast cancer. European Journal of Cancer 36(Suppl 5): S108
Stopa, M.; Streckert, M.; Bonzel, L.; Delvoux, B.; Ten Dijke, P.; Gressner, A.M.; Dooley, S. 2001: Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. Journal of Hepatology 34(Suppl 1): 83
Fiorino, A.; Munoz, N.; Cabrera, B.; Grady, W.M.; Carethers, J.M. 2002: Transforming growth factor beta signaling and transactivation after complementation with a single copy of TGFbeta-receptor II in DNA mismatch-restored colon cancer cells. Gastroenterology 122(4 Suppl 1): A-114
Massuto,D.A.; Kneese,E.C.; Johnson,G.A.; Burghardt,R.C.; Hooper,R.N.; Ing,N.H.; Jaeger,L.A. 2010: Transforming growth factor beta signaling is activated during porcine implantation proposed role for latency-associated peptide interactions with integrins at the conceptus-maternal interface. Reproduction 9(2): 465-478
Park, H.J.; Galper, J.B. 1999: Transforming growth factor beta signaling regulated by Rho GTPases. FASEB Journal 13(5 Part 2): A796
Nair, P.; Adamo, M.; Freeman, J.W. 2001: Transforming growth factor beta signaling regulates insulin-like growth factor-1 receptor expression in the pancreatic cancer cell line MIA PaCa-2. Proceedings of the American Association for Cancer Research 42: 677-678
Taki, H.; Kurokawa, A.; Taki, K.; Harada, S.; Sugiyama, E.; Kobayashi, M. 1999: Transforming growth factor beta stimulates interleukin-6 production by human mesangial cells; involvement of p38 mitogen activated protein kinase pathway. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 522A
Szeto, C.C.; Lai, K.B.; Szeto, C.Y.K.; Wong, T.Y.H.; Li, P.K.T. 2002: Transforming growth factor beta stimulates mesothelial cell production of vascular endothelial growth factor via protein kinase C dependent pathway. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 313A
Copland, J.A.; Maity, T.; Legrand, S.; Tamboli, P.; Taormina, J.; Wood, C.G. 2004: Transforming growth factor beta type 3 receptor is a tumor suppressor gene in conventional renal cell carcinoma. Journal of Urology 171(4 Suppl): 270
Terdiman, J.P.; Gum, J.R.Jr; Levin, T.R.; Conrad, P.G.; Sleisenger, M.H.; Kim, Y.S. 1999: Transforming growth factor beta type II receptor gene mutations are more common than BAX gene mutations in microsatellite instability-related colorectal cancer carcinogenesis. Gastroenterology 116(4 Part 2): A518
Carethers, J.M.; Grady, W.M.; Cabrera, B.L.; Markowitz, S.; Boland, C.R.chard 2001: Transforming growth factor beta unresponsiveness after correcting mutated TGFbeta receptor II by chromosome 3 transfer in DNA mismatch repair restored HCT116+ch3 cells. Gastroenterology 120(5 Suppl 1): A 493
Salah, M.; El Nahas, A.M.; Blakemore, A.I.F. 2001: Transforming growth factor beta-1 SNPs are associated with progressive renal insufficiency. American Journal of Human Genetics 69(4 Suppl): 564
Asselin, E.; Emond, V.; Lambert, R.D.; Fortier, M.A. 1999: Transforming growth factor beta-1 and -2 regulation of prostaglandin synthesis in cultured bovine endometrial cells and cytokine expression in lymphocytes. Theriogenology 51(1): 219
Cole, D.E.C.; Tzakas, P.; Wong, B.Y.L.; Rubin, L.A. 2003: Transforming growth factor beta-1 and peak bone mass Genotype association with quantitative ultrasound in premenopausal women. Calcified Tissue International 72(3): 262
Denver, R.; Tzanidis, A.; Krum, H. 2000: Transforming growth factor beta-1 gene expression is increased in peripheral blood mononuclear cells of chronic heart failure patients Possible contribution of endothelin activation. European Heart Journal 21(Abstract Suppl): 530
Yamada, Y.; Hosoi, T.; Makimoto, F.; Tanaka, H.; Seino, Y.; Ikeda, K. 1999: Transforming growth factor beta-1 gene polymorphism and bone mineral density in Japanese adolescents. American Journal of Medicine 106(4): 477-479
See, F.; Krum, H.; Martin, P.; Tzanidis, A. 2001: Transforming growth factor beta-1 inhibition exacerbates ventricular remodeling early following myocardial infarction. Journal of the American College of Cardiology 37(2 Suppl A): 163A-164A
Norozian, F.; Ryan, J. 2004: Transforming growth factor beta-1 inhibits Fc epsilon RI expression. FASEB Journal 18(4-5): Abstract 552
Argmann, C.A.; Van Den Diepstraten, C.H.; Sawyez, C.G.; Huff, M.W. 1999: Transforming growth factor beta-1 inhibits macrophage cholesteryl ester accumulation induced by native and copper oxidized VLDL remnants. Circulation 100(18): 1; 330
Leehey, D.J.; Song, R.H.; Alavi, N.; Singh, A.K.; Singh, R. 1999: Transforming growth factor beta-1 mediates glucose-induced inhibition of MMP-2 collagenase in rat mesangial cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 686A
Khalil, Mahmoud S.; Blakemore, Alexandra I.F.; El Nahas, Megiud A. 2001: Transforming growth factor beta-1 polymorphisms as a predictor of progressive renal insufficiency. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 817A
Comer, M.T.; Clark, I.M.; Edwards, D.R. 2000: Transforming growth factor beta-1 regulation of metalloproteinase-1,-3 and -9 and tissue inhibitor of metalloproteinases-1 in human fibroblasts. Proceedings of the American Association for Cancer Research 41: 106
Mehdizadehkashi, Z.; Heinrich, M.C. 2001: Transforming growth factor beta-1 signal transduction pathways in prostate cancer cell lines. Human Immunology 62(Suppl 1): S75
Massaeli, H.; Rabinovitch, M. 2002: Transforming growth factor beta-1 upregulates expression and activity of a novel vascular smooth muscle chymase gene. Circulation 106(19): 2; 433
Malkerneker, D.; Lee, Y.C.G.ry; Devin, C.J.; Johnson, J.E.; Thompson, P.J.; Lane, K.B.; Light, R.W. 2000: Transforming growth factor beta-2 but not fibronectin-induced effective pleurodesis. Chest 118(4 Suppl): 151S-152S
Samson, C.M.; Lange, P.A.; Bird, M.A.; Hayden, M.A.; Brenner, D.A.; Behrns, K.E. 2001: Transforming growth factor beta-induced apoptosis in primary murine hapatocytes is caspase-8 dependent. Gastroenterology 120(5 Suppl 1): A 362
Munoz, Olivier; Fend, Falko; De Beaumont, Rosalie; Husson, Herve; Astier, Anne; Freedman, Arnold S. 2003: Transforming growth factor beta-mediated activation of Smad1 in human B cell lymphomas. Blood 102(11): 369a
Steiner, T.; Junker, U.; Schubert, J. 2004: Transforming growth factor beta1 A tumor growth factor in renal cell carcinoma. Journal of Urology 171(4 Suppl): 205
Samson, C.M.; Schrum, L.W.; Behrns, K.E. 2000: Transforming growth factor beta1 activates the Jun kinase but not the NFkappaB signal transduction pathway in rat hepatocytes. Journal of Investigative Medicine 48(1): 38A
Toblli, J.E.; Derosa, G.; Cao, G.; Piorno, P. 2002: Transforming growth factor beta1 and collagen type 1 and III in myocardial tissue in obese and lean Zucker rats. American Journal of Hypertension 15(4 Part 2): 188A
Best, C.M.; Elliget, K.A. 1999: Transforming growth factor beta1 antagonizes the effect of the Rho GTPase inhibitor C3 in NRK-52E cells. FASEB Journal 13(5 Part 2): A685
Baxter, G.F.; Mocanu, M.M.; Brar, B.K.; Latchman, D.S.; Yellon, D.M. 1999: Transforming growth factor beta1 attenuates myocardial injury when given at reperfusion. Circulation 100(18): 1; 9
Arthur, K.J.M.; Ainslie, C.V.; Kluth, D.C.; Rees, A.J. 2000: Transforming growth factor beta1 detection using adenoviral transfection of macrophages. Nephrology Dialysis Transplantation 15(9): A8
Slodkowska, J.; Hasleton, P.S.; Radomski, P. 1999: Transforming growth factor beta1 expression in bronchopulmonary carcinoids. Virchows Archiv 435(3): 367
Haworth, S.E.; Poulton, K.V.; Awad, M.; Sinnott, P.J.; Hull, P.S.; James, J. 1999: Transforming growth factor beta1 genotype frequencies in renal transplant patients with cyclosporin A induced gingival overgrowth. Human Immunology 60(Suppl 2): S63
Petrov, V.; Fagard, R.; Lijnen, P. 2000: Transforming growth factor beta1 induced appearance of myofibroblasts in rat cardiac fibroblasts. Journal of Hypertension 18(Suppl 4): S113
Hori, Y.ichi; Takeyama, Yoshifumi; Ueda, Takashi; Takase, Kozo; Goshima, Masahiro; Yamamoto, Masahiro; Kuroda, Yoshikazu 1999: Transforming growth factor beta1 induces hepatocellular injury in rat severe acute pancreatitis. Gastroenterology 116(4 Part 2): A1319
Bommireddy, R.; Saxena, V.; Ormsby, I.; Yin, M.; Singh, R.R.; Babcock, G.F.; Doetschman, T. 2002: Transforming growth factor beta1 inhibits Ca2+-calcineurin-mediated activation in thymocytes. FASEB Journal 16(5): A1060
Bischoff, S.C.; Gebhardt, T.; Sellge, G.; Lorentz, A.; Werner, U.; Manns, M.P. 2001: Transforming growth factor beta1 inhibits growth and mediator release of human intestinal mast cells. Gastroenterology 120(5 Suppl 1): A 699
Sugiyama, N.; Hui, T.; Mizuguchi, T.; Demetriou, A.A.; Rozga, J. 2001: Transforming growth factor beta1 inhibits proliferation of primary rat hepatocytes through cyclin D1/Cdk4 down-regulation. Hepatology 34(4 Pt 2): 392A
Bachem, M.G.; Kandenwein, J.; Kadlec, N.; Schmid Kotsas, A.; Menke, A.; Siech, M.; Adler, G.; Gruenert, A. 1999: Transforming growth factor beta1 is involved in autocrine stimulated matrix synthesis of pancreatic stellate cells. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S118
Mocanu, M.M.; Baxter, G.F.; Yellon, D.M. 1999: Transforming growth factor beta1 limits infarct size when administered prior to reperfusion in an isolated rat heart model. British Journal of Pharmacology 126(Proceedings Suppl ): 198P
Barcellos Hoff, M.H.; Henshall Powell, R.; Ewan, K.B.; Ravani, S.A.; Arteaga, C.; Akhurst, R.; Warters, R.; Parvin, B. 2002: Transforming growth factor beta1 mediates radiation-induced apoptosis and p53 response in situ. Proceedings of the American Association for Cancer Research 43: 147
Lu, Z.; Gu, Y.; Rooney, S.A. 1999: Transforming growth factor beta1 response elements regulating fatty acid synthase gene expression. FASEB Journal 13(7): A1377
Fong, C.Y.; Pang, L.H.; Holland, E.; Knox, A.J. 1999: Transforming growth factor beta1 stimulated IL-8 release, cyclooxygenase-2 expression and prostaglandin E2 release in human airway smooth muscle cells. British Journal of Pharmacology 128(Proceedings Suppl ): 112P
Wang, Z.; Luo, B.; Sun, J.Z.; Abrams, G.A.; Fallon, M.B. 2001: Transforming growth factor beta1 stimulates endothelin-1 expression in rat cholangiocytes. Hepatology 34(4 Pt 2): 477A
Clements, R.T.; Minnear, F.L.; Vincent, P.A. 2003: Transforming growth factor beta1-induced endothelial myosin light chain phosphorylation, stress fiber formation, and permeability require RhoA and Rho kinase. FASEB Journal 17(4-5): Abstract 161
Lee, Y.C.G.ry; Rogers, J.T.; Thompson, P.J.; Lane, K.B.; Light, R.W. 2000: Transforming growth factor beta2 decreases while talc stimulates IL-8 production from mesothelial cells. Chest 118(4 Suppl): 151S
Goliaei, B.; Soheili, Z. 2000: Transforming growth factor beta2 upregulates GM-CSF gene in human bladder carcinoma cell line HTB 5637. Biochemical Society Transactions 28(5): A341
Lea, J.P.; Tumlin, J.A. 1999: Transforming growth factor enhances the effect of Angiotensin II on calcineurin activity in rat aortic smooth muscle cells but not in kidney epithelial cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 479A-480A
Mcnamee, P.T.; Connolly, J.K.; Middleton, D.; Feeney, S.A.; Savage, D.A.; Maxwell, A.P. 1999: Transforming growth factor gene variants do not influence renal transplant survival. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 737A
Neuman, M.; Benhamou, J.P.; Bourliere, M.; Malkiewicz, I.; Ibrahim, A.; Martinot Peignoux, M.; Shear, N.H.; Lecomte, L.; Asselah, T.; Akremi, R.; Katz, G.; Marcellin, P. 2001: Transforming growth factor levels in chronic hepatitis C reflect the degree of fibrosis Role of therapy with pegylated interferon in reducing fibrosis. Hepatology 34(4 Pt 2): 426A
Leder, H.A.; Donshik, P.; Kreutzer, D.L. 2001: Transforming growth factor receptor expression in human corneal disease. IOVS Investigative Ophthalmology and Visual Science 42(4): S584
Chow, L.C.; Zandian, M.; Matundan, H.; Krueger, R.C.Jr 2002: Transforming growth factor- beta 2 and chondroitin sulfate proteoglycan in human CSF, but not transforming growth factor-beta1, correlate with hydrocephalus in infants. Journal of Investigative Medicine 50(1): 44A
Rios Mendes, F.D.; Alcoberro, J.; Alcaraz, A. 2003: Transforming growth factor-Beta 1 expression and nucleotide consumption as markers of graft viability in NHBD experimental transplant model. Journal of Urology 169(4 Suppl): 482
Shinohara, H.; Williams, C.S.; Koldovsky, O.; Philipps, A.F.; Dvorak, B. 1999: Transforming growth factor-alpha delays gastric emptying and intestinal propulsive motility in suckling rats. Gastroenterology 116(4 Part 2): A1083
Egger, B.; Chai, N.N.; Wang, L.; French, S.W.; Buchler, M.W.; Eysselein, V.E. 1999: Transforming growth factor-alpha is a key mediator in protection and/or repair mechanisms but is not required for tumor formation in murine chronic dextran sulfate colitis. Gastroenterology 116(4 Part 2): A705
Sharma, S.; Takeuchi, S.; Takahashi, S. 2001: Transforming growth factor-alpha is expressed in somatotrophs and mammotrophs in the mouse pituitary gland. Zoological Science 18: 19
Macrae Dell, K.; Nemo, R.; Sweeney, W.E.J.; Avner, E.D. 2003: Transforming growth factor-alpha is not required for cystogenesis in ARPKD. Pediatric Research 53(4 Part 2): 516A
Kato, J.; Inui, N.; Nakano, Y.; Takada, K.; Kuroiwa, G.; Sasaki, K.; Kobune, M.; Takimoto, R.; Fujikawa, K.; Kohgo, Y.; Niitsu, Y. 2000: Transforming growth factor-alpha secreted from ethanol-exposed hepatocyte contributes to development of alcoholic hepatic fibrosis. Alcoholism Clinical and Experimental Research 24(5 Suppl): 176A
Kakeya, T.; Takeuchi, S.; Takahashi, S. 1999: Transforming growth factor-alpha stimulated the differentiation of mammotrophs in the rat pituitary tumor GH3 cell. Zoological Science 16(Suppl ): 5
Petersen, C.; Fröysa, B.; Boitani, C.; Söder, O. 2000: Transforming growth factor-alpha stimulates Sertoli cell proliferation in vitro. Andrologia 32(1): 62-63
Ireland, M.E.; Chen, F.; Mrock, L. 1999: Transforming growth factor-alpha stimulates lens fiber differentiation. IOVS Investigative Ophthalmology and Visual Science 40(4): S561
Ravanti, L.; Hakkinen, L.; Larjava, H.; Saarialho Kere, U.; Kahari, V.M. 1999: Transforming growth factor-b enhances collagenase-3 expression by human gingival fibroblasts via p38 mitogen activated protein kinase. Journal of Investigative Dermatology 112(4): 536
Hishikawa, K.; Nakaki, T.; Fujii, T. 1999: Transforming growth factor-b induces apoptosis via connective tissue growth factor in human vascular smooth muscle cells. Japanese Journal of Pharmacology 79(Suppl 1): 83P
Masi, L.; Malentacchi, C.; Colli, E.; Amedei, A.; Tanini, A.; Brandi, M.; Franchi, A. 2000: Transforming growth factor-b isoform expression in chondrosarcoma of bone Correlation with histologic grade and proliferative activity. Journal of Bone and Mineral Research 15(Suppl 1): S480
Schoenhard, J.A.; Vaughan, D.E. 2002: Transforming growth factor-b regulation of plasminogen activator inhibitor-1 gene expression at the 4G/5G polymorphism. Journal of the American College of Cardiology 39(5 Suppl A): 203A-204A
Feinberg, M.W.; Haspel, R.L.; Watanabe, M.; Takayama, K.; Shimizu, K.; Wang, X.F.; Chen, Z.; Simon, D.I.; Mitchell, R.N.; Jain, M.K. 2002: Transforming growth factor-b1 inhibition of monocyte chemoattractant protein-1 expression is mediated by Smad3. Circulation 106(19): II221
Hatzfeld, J.; Fortunel, N.; Hatzfeld, A. 2000: Transforming growth factor-beta 1 and the high proliferative potential-quiescent stem cell working model. Acta Haematologica (Basel) 103(Suppl 1): 5
Szukiewicz, D.; Szewczyk, G.; Gujski, M.; Wypych, K. 2004: Transforming growth factor-beta 1 and the tonus of isolated placental vessels in normal and hypoxic conditions. FASEB Journal 18(4-5): Abstract 439
Song, B.C.; Chung, Y.H.; Kim, J.A.; Lee, S.S. Lee; Lee, H.C.; Lee, Y.S.; Suh, D.J. 2000: Transforming growth factor-beta 1 as a useful serological marker of small hepatocellular carcinoma. Hepatology 32(4 Pt 2): 614A
Peltier, J.; Bellocq, A.; Perez, J.; Fouqueray, B.; Baud, L. 2000: Transforming growth factor-beta 1 increases glucocorticoid binding and signaling in macrophages through a Smad- and AP-1-mediated process. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 497A-498A
Peltier, J.; Bellocq, A.; Perez, J.; Fouqueray, B.; Baud, L. 2000: Transforming growth factor-beta 1 increases glucocorticoid binding and signalling in macrophages through a Smad-mediated process. Nephrology Dialysis Transplantation 15(9): A3
Chen, W.; Frank, M.; Jin, W.; Lei, K.J.; Hardegen, N.; Wahl, S.M. 2001: Transforming growth factor-beta 1 induces anergic/suppressor CD4+ CD25+ CTLA-4+ T cells. Journal of Leukocyte Biology Suppl: 102
Gebhardt, T.; Lorentz, A.; Sellge, G.; Manns, M.P.; Bischoff, S.C. 2002: Transforming growth factor-beta 1 mediated growth inhibition in human intestinal mast cells is associated with decreased expression of SCF receptor c-kit and abrogated expression of Bcl-X. Gastroenterology 122(4 Suppl 1): A-380
Aziz, T.M.; Burgess, M.; Hasleton, P.S.; Yonan, N.; Deiraniya, A.K.; Hutchinson, I.V. 2001: Transforming growth factor-beta: association with arteriosclerosis and left ventricular dysfunction after heart transplantation. Transplantation Proceedings 33(3): 2334-2336
Shen Yongquan; Li Zailian 2000: Transforming growth factor-beta Immunogenic molecules participating in tuberculous pathogenesis. Zhonghua Jiehe He Huxi Zazhi 23(3): 181-182
Yuan, W.; Varga, J. 2000: Transforming growth factor-beta abrogates IL-1beta-induced collagenase transcription in skin fibroblasts through Smad intracellular signaling. Journal of Investigative Dermatology 114(4): 871
Chua, F.; Dunsmore, S.E.; Clingen, P.; Segal, A.W.; Roes, J.; Laurent, G.J. 2003: Transforming growth factor-beta activation is diminished in fibrosis-resistant neutrophil elastase-deficient mice. Clinical Science (London) 104(Suppl 49): 58P-59P
Carter, J.H.; Carter, H.W.; Richmond, R.E.; Nesnow, S.; Deangelo, A.B. 1999: Transforming growth factor-beta and TGF-beta type II receptor expression during dichloroacetic acid-induced hepatocarcinogenesis. Proceedings of the American Association for Cancer Research 40: 505
Aziz, T.; Yonan, N.; Deiraniya, A.; Campbell, C.; Rahman, A.; Haselton, P.; Hutchinson, I. 1999: Transforming growth factor-beta and allograft vasculopathy following heart transplantation. Journal of Heart and Lung Transplantation 18(1): 37
Geleleite, Tufik Jose; Cardoso De Melo, Guilherme; Costa, Roberto Silva; Da Silva, Cleonice G.A.; Coimbra, Terezila Machado 2001: Transforming growth factor-beta and angiotensin-II during the evolution of the acute tubular necrosis induced by gentamycin. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 780A
Denton, C.P.; Abraham, D.J. 2001: Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Current Opinion in Rheumatology 13(6): 505-511
Morrissey, J.; Guo, G.; Mccracken, R.; Tolley, T.; Fitzgerald, M.; Klahr, S. 2000: Transforming growth factor-beta and fibrotic disease induce jagged-1 expression in renal epithelial cells. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 461A-462A
Klueppelberg, U.; Clark, L.; Smith, E.; Feng, J.; Feit, A.; Batuman, O. 2003: Transforming growth factor-beta and severity of coronary artery disease in women. Blood 102(11): 314a
Sakuraba, H.; Ishiguro, Y.; Tagawa, Y.; Iwakura, Y.; Sekikawa, K.; Munakata, A.; Nakane, A. 2002: Transforming growth factor-beta attenuates mucosal destruction via intestinal epithelial apoptosis through downregulation of excessive gamma interferon production in dextran sulfate sodium-induced colitis. Journal of Interferon and Cytokine Research 22(Suppl 1): S-190
Webb, D.J.; Gonias, S.L. 2001: Transforming growth factor-beta binding site. Official Gazette of the United States Patent and Trademark Office Patents 1253(2)
Han, I.; Hajjar, D.P.; Tauras, J.M.; Feng, J.; Nicholson, A.C. 1999: Transforming growth factor-beta decreases expression of the type B scavenger receptor, CD36. FASEB Journal 13(4 Part 1): A200
Kobie, J.; Lou, S.; Whitesell, L.; Akporiaye, E. 2002: Transforming growth factor-beta diminishes the ability of dendritic cells to stimulate an antitumor immune response. Proceedings of the American Association for Cancer Research 43: 677
Nahta, R.; Esteva, F.J. 2003: Transforming growth factor-beta down-regulation A potential novel mechanism of trastuzumab resistance in breast cancer cells. Breast Cancer Research and Treatment 82(Suppl 1): S88
Jin, S.; Alvarez, E.; Menon, K.E.; Lu, K.; Dempsey, J.A.; Considine, E.L.; Schultz, R.M.; Liu, Q.; Ortiz, M.A.; Teicher, B.A. 2001: Transforming growth factor-beta expression and association with therapy resistance in human SK-HEP1, HS746T and HepG2 gastric and liver CA xenografts. Proceedings of the American Association for Cancer Research 42: 932
Knoflach, A.; Haisch, A.; Binswanger, U. 2000: Transforming growth factor-beta expression in human renal allograft with chronic allograft rejection in patients with cyclosporine or tacrolimus based immunosuppression. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 696A
Serra, R. 2000: Transforming growth factor-beta has parathyroid hormone-related peptide -dependent and -independent effects on the development of endochondral bones. Journal of Bone and Mineral Research 15(Suppl 1): S328
Saarinen, K.; Vaarala, O.; Savilahti, E. 1999: Transforming growth factor-beta in breast milk is a determinant in the development of cows milk allergy. Immunology Letters 69(1): 79-80
Serra, R.A.; Mcdonnell, M.; Bragg, A. 1999: Transforming growth factor-beta in development and disease. Biotecnologia Aplicada 16(4): 205-218
Aziz, T.M.; Burgess, M.I.; Hasleton, P.; Yonan, N.; Hutchison, I.V. 1999: Transforming growth factor-beta in relation to diastolic allograft dysfunction after orthotopic heart transplantation. Circulation 100(18): 1; 391
Alliston, T.N.; Derynck, R. 2000: Transforming growth factor-beta in skeletal development and maintenance. Canalis, Ernesto Author Skeletal growth factors 233-249
Smith, C.A.; Stauber, W.T.; Alway, S.E.; Miller, G.R. 2001: Transforming growth factor-beta in skeletal muscle strain injury. Medicine and Science in Sports and Exercise 33(5 Suppl): S230
Peutz Kootstra, C.; Maes, A.; Heeringa, P.; Heeneman, S.; Lutgens, E.; Daemen, M.J.A.P. 2003: Transforming growth factor-beta independent development of glomerular disease in apolipoprotein E-deficient mice. Journal of the American Society of Nephrology 14(Abstracts Issue): 410A
Dickson, C.; Johnson, H.L.; Webster, D.; Khan, S.A. 2000: Transforming growth factor-beta induced changes in the extracellular matrix and cytoskeleton may mediate its effects on morphological differentiation of rat Leydig cells. Biology of Reproduction 62(Suppl 1): 280
Mucsi, Istvan; Masszi, Andras; Di Ciano, Caterina; Fintha, Attila; Rosivall, Laszlo; Kapus, Andras 2001: Transforming growth factor-beta induced epithelial-mesenchymal transformation in renal tubular cells is associated with prolonged activation of p38 MAP kinase. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 598A
Aicher, W.K. 2004: Transforming growth factor-beta induces elevated interleukin-16 mRNA in synovial fibroblasts. FASEB Journal 18(4-5): Abstract 779
Olman, M.A.; Matthay, M.A. 2003: Transforming growth factor-beta induces fibrosis in immune cell-depleted lungs. American Journal of Physiology. Lung Cellular and Molecular Physiology 285(3): L522-L526
Han, J.; Thakker, G.; Zhou, X.; Hajjar, D.P.; Rosengart, T.K.; Polce, D.R.; Nicolson, A.C. 1999: Transforming growth factor-beta induces the expression of vascular endothelial growth factor through MAP kinase pathway. Circulation 100(18): 1; 405
Ge, R.; Rajeev, V.; Liu, D.; Reiss, M. 2003: Transforming growth factor-beta inhibits cell growth and serum-induced cell migration through distinct post-receptor signaling mechanisms. Proceedings of the American Association for Cancer Research 44: 1039
Fowler, C.A.; Lai, T.; Perks, C.M.; Farndon, J.R.; Holly, J.M.P. 1999: Transforming growth factor-beta inhibits ceramide induced apoptosis in human breast cancer cells and is associated with increased proteolysis of IGFBP-3. Growth Hormone and IGF Research 9(5): 368-369
Tadlock, L.; Patel, T. 2000: Transforming growth factor-beta inhibits growth of human cholangiocytes by decreased proteosomal degradation of p27KIP1. Hepatology 32(4 Pt 2): 432A
Akporiaye, E.T.; Kobie, J.J.; Whitesell, L.J. 2002: Transforming growth factor-beta inhibits in vivo migration and T cell priming by tumor lysate-pulsed dendritic cells. International Journal of Cancer Suppl (13): 153
Takada, K.; Kato, J.; Takimoto, R.; Terui, T.; Niitsu, Y. 1999: Transforming growth factor-beta inhibits the growth of a Smad4-defective MCF-7 cells via p53-dependent manner. Proceedings of the American Association for Cancer Research 40: 100
Matsumoto, K.; Ohi, H.; Kanmatsuse, K. 1999: Transforming growth factor-beta inhibits vascular permeability factor release by T cells in patients with minimal-change nephrotic syndrome. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 590A
Van Royen, N.; Hoefer, I.; Buschmann, I.; Kostin, S.; Heil, M.; Katzer, E.; Piek, J.J.; Schaper, W. 2000: Transforming growth factor-beta is a powerful promotor of arteriogenesis. Journal of the American College of Cardiology 35(2 Suppl A): 307A
Gingery, A.; Pascoe, D.A.; Shaw, A.; Yunker, L.A.; Holy, J.; Oursler, M. 2000: Transforming growth factor-beta is an autocrine survival factor for osteoclasts. Journal of Bone and Mineral Research 15(Suppl 1): S510
Weiler, H.; Fitzpatrick Wong, S. 2000: Transforming growth factor-beta is negatively related to bone formation and positively related to bone resorption in growing piglets. FASEB Journal 14(4): A266
Parmar, D.N.; Mireskandari, K.; Hamblin, H.; Arya, R.; Mchugh, J.D. 2000: Transforming growth factor-beta levels in autologous platelets for macular hole surgery. IOVS Investigative Ophthalmology and Visual Science 41(4): S341
Stern, J.; Miyajima, A.; Chen, J.; Poppas, D.P.; Darracott Vaughan, E.Jr; Felsen, D. 2000: Transforming growth factor-beta mediated expression of p53 and bcl-2 in unilateral ureteral obstruction. Journal of Urology 163(4 Suppl): 84
Aharinejad, S.; Abraham, D.; Grimm, M. 2003: Transforming growth factor-beta mediates cardiac extracellular matrix remodeling in dilated cardiomyopathy. Circulation 108(17): IV520
Chung, T.D.K.; Kim, A.H.; Edmiston, J.; Lebman, D. 2003: Transforming growth factor-beta modulates RAD51 activity and radioresistance in esophageal cancer cells. Proceedings of the American Association for Cancer Research 44: 1230
Shah, A.H.; Lee, C. 2000: Transforming growth factor-beta modulation in bladder cancer immunotherapy. European Urology 38(4): 512
Lavoie, P.; Robitaille, G.; Agaharazii, M.; Lebel, M.; Lariviere, R. 2003: Transforming growth factor-beta neutralizing antibody attenuates renal injury and hypertension in uremic rats. Journal of the American Society of Nephrology 14(Abstracts Issue): 145A
Ahdjoudj, S.; Lasmoles, F.; Holy, X.; Zerath, E.; Marie, P.J. 2001: Transforming growth factor-beta prevents and reverses bone marrow adipogenesis induced by skeletal unloading in rats. Journal of Bone and Mineral Research 16(Suppl 1): S143
Liu, P.; Teicher, B.A. 1999: Transforming growth factor-beta production, type I and type II receptor expression and response to anticancer agents, radiation, and TGFbeta of three human hepatocellular and four gastric cancer cell lines. Proceedings of the American Association for Cancer Research 40: 337
Jian, B.; Mohler, E.R.IIi; Jones, P.L.; Levy, R.J. 1999: Transforming growth factor-beta promotes aortic valve interstitial cell calcification. Circulation 100(18): 1; 706
Zhang, Y.E.; Yu, L.; Hebert, M.C. 2002: Transforming growth factor-beta receptor activated p38 MAP kinase mediates Smad-independent TGF-beta responses. Proceedings of the American Association for Cancer Research 43: 153
Zhao, Y.n 2000: Transforming growth factor-beta receptor signaling and lung development. Mendelson, Carole R Author Contemporary Endocrinology; Endocrinology of the lung: Development and surfactant synthesis 241-254
Ikeda, H.; Yoshimoto, T.; Shida, N.; Nakayama, K.; Oshima, M.; Taketo, M.; Miypshi, I. 2000: Transforming growth factor-beta receptor type II and p27 genes are critical in estrogen-induced pituitary tumorigenesis. Brain Pathology 10(4): 747-748
Shaw, G.L.; Munoz Antonia, T.; Anderson, M.A.; Gruidl, M.; Muro Cacho, C.A. 1999: Transforming growth factor-beta receptor type II expression as a potential intermediate endpoint marker of cervical neoplasia. Proceedings of the American Association for Cancer Research 40: 432
Stevens, C.M.; Dressman, M.; Wolfgang, C.D.; Lavedan, C. 2002: Transforming growth factor-beta receptor type III expression levels are down-regulated in cancerous tissues. American Journal of Human Genetics 71(4 Suppl): 253
Agrotis, A.; Condron, M.; Bray, P.; Bobik, A. 2000: Transforming growth factor-beta receptors and SMAD expression in smooth muscle from spontaneously hypertensive rats. Journal of Hypertension 18(Suppl 4): S187
Basile, D.P.; Osborn, J.L. 1999: Transforming growth factor-beta receptors are enhanced in kidney following ischemic injury. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 628A
Philip, A.; Wong, S.H. 1999: Transforming growth factor-beta receptors on skin microvascular endothelial cells Formation of heterooligomeric complexes. Journal of Burn Care and Rehabilitation 20(1 Part 2): S222
Mckeon, R.J.; Griffith, R. 2000: Transforming growth factor-beta regulates the astrocytic production of axon growth promoting and growth inhibitory molecules after CNS injury. Journal of Neurochemistry 74(Suppl ): S97
Hentges, S.; Sarkar, D.K. 2001: Transforming growth factor-beta regulation of estradiol-induced prolactinomas. Frontiers in Neuroendocrinology 22(4): 340-363
Monkawa, T.; Shankland, S.J. 2000: Transforming growth factor-beta requires the cyclin-dependent kinase -inhibitors p21 and p27 to induce mesangial cell hypertrophy. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 461A
Tornatore, K.M.; Fountaine, R.; Hom, J.; Difrancesco, R.; Reed, K.A.; Venuto, R.C. 1999: Transforming growth factor-beta serum concentration measurement in stable renal transplant recipients. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 767A
Yue, J.; Mulder, K.M. 2001: Transforming growth factor-beta signal transduction in epithelial cells. Pharmacology and Therapeutics 91(1): 1-34
Leong, G.M.; Subramaniam, N.; Flanagan, J.L.; Eisman, J.A.; Gardiner, E.M.; Kouzmenko, A.P. 2000: Transforming growth factor-beta signalling through the nuclear cofactor Skip. Bone (New York) 27(4 Suppl): 18S
Palmer, G.; Guicheux, J.; Bonjour, J.P.; Caverzasio, J. 1999: Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type III Pi transporter Glvr-1 in chondrogenic ATDC5 cells. Journal of Bone and Mineral Research 14(Suppl 1): S426
Selvamurugan, N.; Fung, Z.; Partridge, N.C. 2002: Transforming growth factor-beta stimulation of collagenase-3 expression in human breast cancer cells. Journal of Bone and Mineral Research 17(Suppl 1): S311
Gupta, V.; Harkin, D.P.; Kawakubo, H.; Maheswaran, S. 2004: Transforming Growth Factor-beta superfamily: evaluation as breast cancer biomarkers and preventive agents. Current Cancer Drug Targets 4(2): 165-182
Chen, T.; Carter, D.; Reiss, M. 1999: Transforming growth factor-beta type I receptor kinase mutant associated with metastatic breast cancer. Proceedings of the American Association for Cancer Research 40: 268
Yang, S.P.; Winyard, P.J.; Woolf, A.S. 2000: Transforming growth factor-beta upregulation in experimental renal dysplasia correlates with cyst formation and an epithelial/mesenchymal switch. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 385A
Parker, E.; Bloor, C.A.; Knight, R.A.; Spiteri, M.A.; Allen, J.T. 2000: Transforming growth factor-beta-induced changes in insulin-like growth factor binding protein expression in lung fibroblasts. Thorax 55(Suppl 3): A15
Petrov, V.; Fagard, R.; Lijnen, P. 1999: Transforming growth factor-beta-induced differentiation of cardiac fibroblasts to myofibroblasts is accompanied by an increase in angiotensin-converting enzyme activity. European Heart Journal 20(ABSTR Suppl ): 94
Seeland, U.; Haeuseler, C.; Hinrichs, R.; Pfitzner, T.; Scharffetter Kochanek, K. 2001: Transforming growth factor-beta1 - induced myocardial fibrosis is associated with an inhibition of interstitial collagenase activity in transgenic mice. Circulation 104(17): 2; 187
Rodriguez Barbero, A.; Dorado Plaza, F.; Obreo, J.; Pandiella, A.; Sanchez, A.; Lopez Novoa, J.M. 2002: Transforming growth factor-beta1 -induced COX-2 expression in human mesangial cells is mediated by MAPK activation. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 739A
Lijnen, P.; Petrov, V.; Fagard, R.R. 2000: Transforming growth factor-beta1 -induced increase in ACE and ACE-like activity in cardiac fibroblasts. American Journal of Hypertension 13(4 Part 2): 42A
Schlabritz Loutsevitch, N.E.; Salmassi, A.; Mettler, L. 2000: Transforming growth factor-beta1 and -beta2 in physiological concentrations enhanced oestradiol, but not inhibin release, from human granulosa-luteal cells in leukocytes free culture. Molecular and Cellular Endocrinology 164(1-2): 257
Cardillo, M.R.; Lazzereschi, D.; Macri, D.; Di Silverio, F.; Colletta, G.; Castagna, G. 1999: Transforming growth factor-beta1 and SMADs in human kidney neoplasia. Virchows Archiv 435(3): 324
Boehmer, K.P.; Riess, R.; Bitzer, M.; Gottsmann, M.; Veelken, R. 1999: Transforming growth factor-beta1 and TGF-beta - receptors in type II diabetic patients with diabetic nephropathy. Kidney and Blood Pressure Research 22(4-6): 278
Chen, C.A.; Chen, H.C.; Hwang, J.C.; Lin, J.R.; Guh, J.Y.; Lai, Y.H. 2002: Transforming growth factor-beta1 and integrin promote rat podocytes with phenotypic change of positive alpha-smooth muscle actin in vitro. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 204
Kang, Y.; Wakefield, L.M.; Diwan, B.; Moody, T.W.; Jakowlew, S.B. 2000: Transforming growth factor-beta1 and receptor II may function as tumor suppressors in mouse lung carcinogenesis. Proceedings of the American Association for Cancer Research 41: 849
Hui, W.; Rowan, A.D.; Cawston, T.E. 2000: Transforming growth factor-beta1 blocks the release of collagen fragments from bovine nasal cartilage stimulated by interleukin-1alpha in combination with oncostatin M. International Journal of Experimental Pathology 81(3): A9-A10
Pala, L.; Cresci, B.; Giannini, S.; Manuelli, C.; Cappugi, P.; Rotella, C.M. 2001: Transforming growth factor-beta1 counteracts the protective effect of vascular endothelial growth factor receptor 2 in human glomerular endothelial cells. Diabetologia 44(Suppl 1): A265
Arthur, K.J.M.; Ainslie, C.V.; Kluth, D.C.; Rees, A.J. 1999: Transforming growth factor-beta1 detection using adenoviral transfection of cells. Immunology 98(Suppl 1): 108
Tsamandas, A.C.; Felekouras, E.S.; Papalampros, E.L.; Lee, R.G. 2000: Transforming growth factor-beta1 expression in chronic hepatitis type B or type C. Laboratory Investigation 80(3): 191A
Wang, C.M.; Chang, Y.Y.; Hung, A.C.; Jang, T.H.; Sun, S.H. 1999: Transforming growth factor-beta1 expression is involved in the growth regulation of a type-2 astrocyte cell line, RBA-2. Society for Neuroscience Abstracts 25(1-2): 1698
Lane, P.H.; Snelling, D.M.; Hollman, A.; Langer, W.J. 2000: Transforming growth factor-beta1 expression is stimulated less in the kidney of prepubertal than mature rats with diabetes. Diabetes Research and Clinical Practice 50(Suppl 1): S227
Patel, A.; Rippin, J.D.; Scott, W.R.; Lympany, P.A.; Barnett, A.H.; Bain, S.C. 2003: Transforming growth factor-beta1 gene contributes to the genetic predisposition to nephropathy in Type 1 diabetes. Diabetologia 46(Suppl 2): A111
Knoflach, A.; Guo, Z.; Binswanger, U. 2001: Transforming growth factor-beta1 gene expression and protein in renal transplanted patients with stable and intermediate transplant function and renal allograft dysfunction Differences between cyclosporine or tacrolimus based immunosuppression. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 902A
Knoflach, A.; Zhongning, G.; Binswanger, U. 2001: Transforming growth factor-beta1 gene expression in patients with stable renal allograft function and chronic renal allograft dysfunction Differences between cyclosporine or tacrolimus based immunosuppression. Nephrology Dialysis Transplantation 16(6): A202
Krum, H.; Denver, R.; Tzanidis, A. 2001: Transforming growth factor-beta1 gene expression is increased in mononuclear cells of patients with chronic heart failure Implications for cardiac remodeling. Journal of the American College of Cardiology 37(2 Suppl A): 166A
Jang, W.H.; Yang, Y.I.; Lee, Y.J.; Chun, J.H.; Yea, S.S.; Paik, K.H. 2001: Transforming growth factor-beta1 gene polymorphism is related to HBV-associated hepatocarcinogenesis. Hepatology 34(4 Pt 2): 671A
Kohli, G.; Clelland, E.; Dimuccio, T.; Peng, C. 2003: Transforming growth factor-beta1 in zebrafish ovary cDNA cloning, mRNA expression and role in oocyte maturation. SICB Annual Meeting and Exhibition Final Program and Abstracts : 217
Minami, M.; Kume, N.; Kataoka, H.; Moriwaki, H.; Morimoto, M.; Sawamura, T.; Masaki, T.; Kita, T. 1999: Transforming growth factor-beta1 increase the expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells and smooth muscle cells. Circulation 100(18): 1; 743
Shek, F.W.; Williams, E.J.; Walker, F.M.J.; Iredale, J.P.; Fine, D.R. 2000: Transforming growth factor-beta1 increases collagen synthesis and inhibits proliferation of rat pancreatic stellate cells. Pancreas 21(4): 478
Satterwhite, D.J.; Neufeld, K.L.; White, R.L. 1999: Transforming growth factor-beta1 inhibits topoisomerase IIalpha expression independent of cell cycle arrest. Pediatric Research 45(4 Part 2): 152A
Denver, R.; Tzanidis, A.; Pepe, S.; Quick, D.; Krum, H. 2003: Transforming growth factor-beta1 mediated cardiac fibrosis in chronic heart failure Potential contribution of activated lipopolysaccharide. European Heart Journal 24(Abstract Suppl): 17
Li, C.M.; Khosla, J.; Hoyle, P.; Sannes, P.L. 2001: Transforming growth factor-beta(1) modifies fibroblast growth factor-2 production in type Ii cells. Chest 120(1 Suppl): 60s-61s
Hetzel, G.R.; Plum, J.; Ozcan, F.; Heering, P.; Grabensee, B. 2001: Transforming growth factor-beta1 plasma levels in stable renal allograft recipients under different immunosuppression. Transplantation 71(4): 586-587
Dai, C.; Yang, J.; Liu, Y. 2002: Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 94A-95A
Bye, N.; Nichols, N.R. 2002: Transforming growth factor-beta1 reduces induced apoptosis without affecting proliferation in the adult hippocampus. Developmental Brain Research 134(1-2): A38, 31 March
Allam, J.P.; Geiger, E.; Bieber, T.; Novak, N. 2003: Transforming growth factor-beta1 regulates the expression of the high affinity receptor for IgE on CD34+ stem cells derived dendritic cells. Journal of Investigative Dermatology 121(5): 1240
Lin, M.; Fong, Y.C.; Mcdonnell, P.J.; Bryant, M.R. 1999: Transforming growth factor-beta1 regulation of collagenase, 75-kDa progelatinase, and metalloproteinase inhibitor in human fetal scleral fibroblasts. IOVS Investigative Ophthalmology and Visual Science 40(4): S453
Holland, T.A.; Tessmar, J.K.V.; Tabata, Y.; Mikos, A.G. 2004: Transforming growth factor-beta1 release from oligo fumarate hydrogels in conditions that model the cartilage wound healing environment. Journal of Controlled Release 94(1): 101-114, 8 January
Huynh, M.L.n N.; Fadok, V.A.; Henson, P.M. 2001: Transforming growth factor-beta1 secretion from murine macrophages is released by in vivo ingestion of apoptotic cells. Chest 120(1 Suppl): 3S
Park, S.J.; Chang, E.J.; Ko, J.S.; Kim, H.M. 2002: Transforming growth factor-beta1 selectively activates p38 mitogen-activated protein kinase and NF-kappaB upon RANK stimulation. Journal of Bone and Mineral Research 17(Suppl 1): S431
Durante, W.; Hassan, S.; Ensenat, D.; Reyna, S.V.; Schafer, A.I. 2001: Transforming growth factor-beta1 stimulates vascular smooth muscle cell L-proline transport by inducing system A gene expression. FASEB Journal 15(4): A455
Chen, H.H.; Zhao, S.; Song, J.G. 2002: Transforming growth factor-beta1 suppresses serum deprivation-induced apoptosis via activation of ERK1/ERK2 and the inhibition of p38 activity and ceramide production. Cell Research 12(3-4): 298
Chow, L.C.; Soliman, A.; Zandian, M.; Danielpour, M.; Krueger, R.C.J. 2003: Transforming growth factor-beta1,beta2 , chondroitin sulfate proteoglycans , and nitrated CSPGs in cerebrospinal fluid Prediction of ventriculoperitoneal shunt after intraventricular hemorrhage in preterm infants. Pediatric Research 53(4 Part 2): 351A
Greenberg, S.J.; Pan, J.J.; Plunkett, R.J.; Barone, T.A.; Choi, U.; Stiles, J.D.; Spence, P.O.; Ostrow, P.T. 2001: Transforming growth factor-beta1/receptor regulation of human astroglioma. Neurology 56(8 Suppl 3): A481
Soliman, A.; Chow, L.C.; Zandian, M.; Danielpour, M.; Krueger, R.C.J. 2003: Transforming growth factor-beta2 , chondroitin sulfate proteoglycans , and nitrated CSPGs in human cerebrospinal fluid correlate with periventricular leukomalacia and neurologic outcome. Pediatric Research 53(4 Part 2): 540A
Hill, C.; Flyvbjerg, A.; Bak, M.; Logan, A. 2000: Transforming growth factor-beta2 antagonist attenuates fibrosis in the experimental diabetic rat kidney. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 643A
Shek, F.W.; Li, K.F.; Mann, J.; Williams, E.J.; Iredale, J.P.; Beynon, R.C.; Fine, D.R. 2004: Transforming growth factor-beta3 expresses anti-fibrotic properties in pancreatic stellate cells. Gut 53(Suppl 3): A16
Wada, M.; Sheng, H.; Saha, D.; Shao, J.; Beauchamp, R.D.niel 1999: Transforming growth factor-betainduction of cyclooxygenase-2 requires RhoB in rat intestinal epithelial cells. Gastroenterology 116(4 Part 2): A942
Todorovic Rakovic, N.; Ivanovic, V.; Demajo, M.; Neskovic Konstantinovic, Z.; Nikolic Vukosavljevic, D. 2004: Transforming growth factor-betal and steroid receptor status in breast cancer. EJC Suppls 2(3): 105
Javelaud, D.; Mauviel, A. 2004: Transforming growth factor-betas: smad signaling and roles in physiopathology. Pathologie-Biologie 52(1): 50-54
Chen, S.; Ge, M.; Xing, F. 2003: Transforming growth factorbeta1 level in follicular fluid undergoing ovarian stimulation and in vitro fertilization correlates to oocyte maturation and pregnancy. Fertility and Sterility 80(Suppl 3): S282
Opperman, L.A.; Adab, K.; Gakunga, P.T. 2000: Transforming growth factors regulate intramembranous bone growth by regulating rates of cell proliferation and apoptosis. Journal of Bone and Mineral Research 15(Suppl 1): S327
Shacka, J.J.; Kim, E.S.; Parks, W.T.; Ren, R.F.; Flanders, K.C. 1999: Transforming growth factors-beta protect against oxidative stress in neuronal culture. Society for Neuroscience Abstracts 25(1-2): 338
Gypmantasiri, P.; Limnirankul, B. 2002: Transforming highland agriculture for sustainable livelihoods of ethnic communities in Northern Thailand. AAAS Annual Meeting and Science Innovation Exposition 168: A46, 14-19 February
Soparkar, C.N.; Patrinely, J.R.; Hunt, M.G.; Shenaq, S.M. 2001: Transforming mucous membrane grafts into skin grafts. Ophthalmology 108(11): 1933-1934
Favre, D.; Hantz, O.; Trepo, C. 2002: Transforming potential of hepatitis B virus. International Journal of Cancer Suppl (13): 85
Kongkathip, N.; Pradidphol, N.; Hasitapan, K.; Grigg, R.; Kao, W.-C.; Hunte, C.; Fisher, N.; Warman, A.J.; Biagini, G.A.; Kongsaeree, P.; Chuawong, P.; Kongkathip, B. 2010: Transforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agents. Journal of Medicinal Chemistry 53(3): 1211-1221
Ziv, M. 2002: Transforming the dry message of implementing legislation into a hot communicative item. International Journal of Cancer Suppl (13): 75
Pinheiro, A.Rizzolo.de.Oliveira.; de Carvalho, M.de.Fátima.Cruz.Correia. 2010: Transforming the hunger problem into food and nutritional approach: a continuous social inequality. Ciencia and Saude Coletiva 15(1): 121-130
Abrahams,C. 2010: Transforming the region supermarkets and the local food economy. African Affairs 9(434): 115-134
White, H.B.IIi 1999: Transforming undergraduate education Problem-based learning at the University of Delaware. FASEB Journal 13(7): A1335
Calandrella, L.E.; Schreiber, V.; Smith, A.T. 2001: Transforming without destroying Community development and ecological preservation in the Amazon river basin. AAAS Annual Meeting and Science Innovation Exposition 167: A93, February 15-20
Kajdaniuk, D.; Marek, B.; Swietochowska, E.; Ciesielska Kopacz, N.; Nowak, B.; Wielkoszynski, T. 1999: Transforming-like growth factor beta1 and its interactions with chosen hormones in stage II breast cancer patients on adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-Fluorouracil. Breast Cancer Research and Treatment 57(1): 91
Medabalimi, J.L. 1999: Transframe peptide inhibitor of viral protease. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2545
Pereira, L.; Bega, G.; Broth, R.; Agrawala, G.; Farrell, C.; Berghella, V. 2002: Transfundal pressure improves the predictive value of transvaginal ultrasound in high-risk patients with a cervical length gtoreq25 mm. American Journal of Obstetrics and Gynecology 187(6 Suppl): S208
Schmidt, P.J.; Washington, G.; Thornton, W. 2002: Transfuse George Washington!. Transfusion 42(2): 275-277
Gilstad, C.W.; Kessler, C.; Sandler, S.G. 2002: Transfusing patients with anti-immunoglobulin a subclass antibodies. Vox Sanguinis 83(4): 363
Nedeljkovic, N.; Antic, M.; Gogic, S. 2000: Transfusion Medicine Specialists Section of the Serbian Medical Doctors Society. Vox Sanguinis 78(Suppl 1): P741
Henschler, R. 2002: Transfusion Pathology and relevance of leukocyte reduction. Matheis, Georg , Moritz, Anton , Scholz, Martin Leukocyte depletion in cardiac surgery and cardiology 33-43
Griffith, L.M.; Wesley, R.A.; Childs, R.W.; Conley, B.; Carter, C.S.; Read, E.J.; Stroncek, D.F.; Barrett, A.J.; Bolan, C.D.; Leitman, S.F. 2002: Transfusion Support Following Nonmyeloablative or Myeloablative Allogeneic Hematopoietic Cell Transplantation - CD34 Cell Dose and Red Cells Transfused Pretransplant Predict Intensity of Support and Time to Transfusion Independence. Blood 100(11): Abstract No. 1088
Avsar, M.; Ture, F.; Avsar, E.; Tamar, D.; Akkiprik, M.; Geyik, G.; Hamazaoglu, H.O.; Cirakoglu, B.; Tozun, N. 2000: Transfusion Transmitted virus in IV drug abusers in Turkey. Journal of Hepatology 32(Suppl 2): 196
Popovsky, M.A. 2004: Transfusion and the lung: circulatory overload and acute lung injury. Vox Sanguinis 87(Suppl 2): 62-65
Stainsby, D.; Love, E.; Jones, H.; Cohen, H.; Eglin, R.; Mcdonald, C.; Soldan, K. 2003: Transfusion associated bacterial contamination Serious Hazards of transfusion programme. British Journal of Haematology 121(Suppl 1): 79-80
Bauer, M.; Biedler, A.; Rensing, H.; Bauer, I.; Schneider, S.; Grenner, S.; Paxian, M.; Larsen, R.; Seyfert, U.T. 2000: Transfusion associated dysturbances of monocytes. Vox Sanguinis 78(Suppl 1): P635
Choudhury, N. 2000: Transfusion associated filariasis in an endemic area. Vox Sanguinis 78(Suppl 1): P385
Arat, M.; Aslan, V.; Arslan, O.; Kurt, M.; Gulbas, Z. 2000: Transfusion associated graft versus host disease 3 Cases in Turkey. Vox Sanguinis 78(Suppl 1): P642
Kerr, R.; Gelly, K.J.; Rawlinson, S.; Norris, A.; Bowen, D.T. 1999: Transfusion associated graft versus host disease in a patient with high grade B cell lymphoma Should we be irradiating cellular products for patients with Non Hodgkins Lymphoma?. British Journal of Haematology 105(Suppl 1): 52
Garrison, M.A.; Bailey, J.K.; Pollack, M.S.; Elston, D.M.; Libow, L.; Sheffler, R.L. 2000: Transfusion associated graft-versus-host disease in an apparently immunocompetent patient initially identified as toxic epidermal necrolysis. Blood 96(11 Part 2): 106b-107b
Gouzovski, E.E.; Logkin, A.V.; Kozinetc, G.I. 2000: Transfusion audit in Moscow hospital for adults. Vox Sanguinis 78(Suppl 1): P723
Gibson, B.E.S.; Todd, A.; Roberts, I.; Pamphilon, D.; Rodeck, C.; Bolton-Maggs, P.; Burbin, G.; Duguid, J.; Boulton, F.; Cohen, H.; Smith, N.; McClelland, D.B.L.; Rowley, M.; Turner, G. 2004: Transfusion guidelines for neonates and older children. British Journal of Haematology 124(4): 433-453
Williamson, L.M. 2002: Transfusion hazard reporting: powerful data, but do we know how best to use it?. Transfusion 42(10): 1249-1252
Ragimov, A.A.; Dashkova, N.G. 2003: Transfusion immunology. Immunologiya 24(6): 338-341
Kawamura, A. 2002: Transfusion in Japan. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 26(2): 113-114
Hardy, J-François. 2002: Transfusion in elderly patients with myocardial infarction. New England Journal of Medicine 346(10): 779-782
Cabrera, M.E.; Quintana, J.; Campbell, M.; Ford, A.; Greaves, M.F. 1999: Transfusion induced ATLL. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(4): A63
Movshev, B.E.; Vitvitsky, V.M.; Lisovskaya, I.L.; Ataullakhanov, F.I. 2001: Transfusion media Applied and basic aspects. Gematologiya i Transfuziologiya 46(3): 74-82
Pachmann, U.; Jungwirth Schill, C.; Stein, E.L. 2000: Transfusion medical pharmacology abciximab selectively interferes with binding of human anti platelet auto- and alloantibodies of GPIIb/IIIa as monitored by PSIFT and MAIPA. Vox Sanguinis 78(Suppl 1): P064
Goodnough, L.T.; Brecher, M.E.; Kanter, M.H.; Aubuchon, J.P. 1999: Transfusion medicine - Blood transfusion. New England Journal of Medicine 340(6): 438-447, . 11
McCullough, J. 2003: Transfusion medicine: discipline with a future. Transfusion 43(6): 823-828
Goodnough, L.T. 2002: Transfusion medicine Dr Goodnough replies. New England Journal of Medicine 347(7): 538-539
Llewelyn, C.; Amin, M.; Ballard, S.; Buck, J.; Rege, K.; Casbard, A.; Murphy, M.; Williamson, L.M. 2002: Transfusion medicine epidemiology pilot study. British Journal of Haematology 117(Suppl 1): 77
Van Aken, W.G. 2000: Transfusion medicine in the 3rd millennium. Vox Sanguinis 78(Suppl 2): 71-74
Smith, M.A.; Fomovskaia, G.N.; Fomovsky, M.A.; Butt, N.J.; Baker, M. 2003: Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies. Official Gazette of the United States Patent and Trademark Office Patents 1277(5)
Mendes, P. 2002: Transfusion medicine technology transfer: traps to avoid. Transfusion Medicine Reviews 16(1): 25-33
Murphy, S.; Snyder, E.; Cable, R.; Slichter, S.; Strauss, R.; Mccullough, J.; Lin, J.S.; Corash, L.; Conlan, M.G. 2003: Transfusion of INTERCEPT Platelets vs reference platelets at doses gtoreq30X1011 results in comparable hemostasis and platelet and RBC transfusion requirements Results of the SPRINT Trial. Blood 102(11): 815a
Wang, L.F.; Laskus, T.; Nowicki, M.; Mosley, J.W.; Radkowski, M.; Rakela, J. 1999: Transfusion of blood from four hepatitis C virus positive donors into a naive recipient results in the predominance of a single strain. Hepatology 30(4 Part 2): 454A
Sun, E.W.; Gao, Y.; Chen, J.F.; Shi, Y.F. 2002: Transfusion of donor apoptotic splenocytes prolongs cardiac allograft survival in absence of immunosuppression. Cell Research 12(3-4): 284
Sumida, S. 2000: Transfusion of frozen platelets. Vox Sanguinis 78(Suppl 1): P190
Joos, K.; Herzog, R.; Einsele, H.; Handgretinger, R.; Northoff, H.; Neumeister, B. 2001: Transfusion of granulocyte concentrates received from donors primed with G-CSF in neutropenic patients with life-threatening infections. Infection 29(Suppl 1): 73
Bilgin, Y.M.; Van, D.W.tering, L.M.G.; Lorinser, J.E.; Versteeg, M.I.M.; Eijsman, L.; Van Oers, M.H.J.; Brand, A. 2002: Transfusion of leukocyte-depleted erythrocytes reduces the rate of mortality in cardiac surgery. Vox Sanguinis 83(Suppl 2): 134
Ahmad, M.; Hansen, A. 2003: Transfusion of packed Red Blood cells stored 10 days may not be helpful in weaning off oxygen supplements in premature infants. Pediatric Research 53(4 Part 2): 464A-465A
Ahmad, M.; Elsesser, M. 2003: Transfusion of packed red blood cells stored for 10 days may be associated with decreased head circumference. Pediatric Research 53(4 Part 2): 464A
Fontaine, O.; Schneider, T.; Schooneman, F.; Deram, G.; Taverne, D.; Pouleur, I.; Houndo, L.; Huart, J.J.cques 2002: Transfusion of plateletpheresis concentrates and adverse events. Vox Sanguinis 83(Suppl 2): 86
Carpani, G.; Bozzo, M.; Sinnone, M.S.; Fusconi, A.; D'amato, B.; Moroni, G.; Pardi, G. 2000: Transfusion policy in HELPP syndrome. Vox Sanguinis 78(Suppl 1): P246
Grouzi, E.; Assimakopoulou, T.; Palla, A.; Panagou, I.; Spiliotopoulou, I. 2000: Transfusion practice in primary total joint replacements among different teams of surgeons in the same hospital. Vox Sanguinis 78(Suppl 1): P724
Frey, L.; Spannagl, M.; Berger, K.C.; Hoffmann, J.; Wittmann, C.; Schramm, W. 2002: Transfusion practice of blood components and blood derivates in Germany. Vox Sanguinis 83(Suppl 2): 225
White, J.R.; Eichelberger, M.; Dalton, H. 2002: Transfusion practices in critically injured children. Pediatric Research 51(4 Part 2): 51A
Styles, L.A.; Abboud, M.; Larkin, S.; Lo, M.; Kuypers, F.A. 2007: Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. British Journal of Haematology 136(2): 343-344
Sage, D.; Brown, C.; Lucas, G.; Win, N.; Navarrete, C. 2002: Transfusion related acute lung injury Laboratory investigations. European Journal of Immunogenetics 29(2): 142
Stainsby, D.; Cohen, H.; Jones, H.; Beatty, C.; Williamson, L. 2004: Transfusion related acute lung injury a major cause of transfusion associated mortality and morbidity. British Journal of Haematology 125(Suppl 1): 34
Carter, V.; Cavanagh, G.; Lubenko, A.; Matthews, C.J.; Chapman, C.E. 2003: Transfusion related acute lung injury caused solely by class II HLA antibodies 3 cases. Human Immunology 64(Suppl 1): S76
Bojanic, I.; Golubic Cepulic, B.; Mazic, S.; Plenkovic, F.; Ivankovic, Z.; Lukic, M.; Bogdanic, V.; Sertic, D.; Mrsic, M.; Serventi, R.; Labar, B. 2002: Transfusion requirements of patients after allogenic hematopoietic stem cell transplantation. Vox Sanguinis 83(Suppl 2): 94
Ray, V.L.; Chaudhary, R.K.; Choudhury, N. 2000: Transfusion safety in developing countries and the Indian scenario. Developments in Biologicals 102: 195-203
Dautry-Varsat, A.; Balañá, M.ía.E.; Wyplosz, B. 2004: Chlamydia--host cell interactions: recent advances on bacterial entry and intracellular development. Traffic 5(8): 561-570
Dzik, W.H. 2002: Transfusion safety, 2001. Developments in Biologicals 108: 3-7
Jorreto, M.; Andion, I.; Quiroga, H.; Aranda, D.; Alves, H.; Costa Maia, J.; Pereira, R. 2001: Transfusion support on liver transplantation Hospital S Joao - Porto. European Journal of Immunogenetics 28(2): 270
Sovic, D.; Kolak, J.; Dodig, J. 2002: Transfusion therapy of patients in UIC. Vox Sanguinis 83(Suppl 2): 215
Cook, L.O. 2000: Transfusion therapy of sickle cell disease A blood bankers perspective. Annals of Clinical and Laboratory Science 30(3): 314
Remesar, M.; Oknaian, S.; Del Pozo, A. 2002: Transfusion transmissible infections markers development over an eight-year period in a hospital blood bank in Argentina. Vox Sanguinis 83(Suppl 2): 195-196
Hollinger, F.B.; Kleinman, S. 2003: Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives. Transfusion 43(8): 992-997
Wong, E.C.; Baxter, C.A.; Farrelly, E.E.; Criss, V.R.; Frey, C.; Huang, Z.; Luban, N.L.C. 2002: Transfusion transmitted viral disease and deferral rates in parental, directed and community donors for pediatric patients. Pediatric Research 51(4 Part 2): 232A
Das, K.; Gupta, R.K.; Das, B.C.; Kar, P. 2000: Transfusion transmitted virus Clinical relevance in acute liver failure. American Journal of Gastroenterology 95(9): 2510
Frangos, S.G. 2004: Transfusion trigger: a careless term that disregards pathophysiology. PharmacoTherapy 24(7): 950
Carson, J.L.; Hill, S.; Carless, P.; Hébert, P.; Henry, D. 2002: Transfusion triggers: a systematic review of the literature. Transfusion Medicine Reviews 16(3): 187-199
Carson, J.L.; Ferreira, G. 2004: Transfusion triggers: how low can we go?. Vox Sanguinis 87(Suppl 2): 218-221
Paul, D.A.; Leef, K.H.; Locke, R.; Stefano, J.L. 1999: Transfusion volume in very low birth weight infants A randomized study of 10 vs 20 cc/kg. Pediatrics 104(3 Part 3): 741
Davoren, A.; Curtis, B.; Shulman, I.A.; Mohrbacher, A.F.; Bux, J.; Kwiatkowska, B.; Mcfarland, J.G.; Aster, R.H. 2002: Transfusion-Related Acute Lung Injury Due to Neutrophil-Agglutinating HNA-3a Antibodies in Donor Plasma - A Report of 2 Fatalities. Blood 100(11): Abstract No. 2795
Roback, J.D.; Gillespie, T.W.; Kelley, V.; Saakadze, N.; Hillyer, C.D. 2002: Transfusion-Transmitted CMV Infection in a Mouse Model High Load of Latent Virus Required for Transmission. Blood 100(11): Abstract No. 82
Boshkov, L.K. 2002: Transfusion-associated acute lung injury An evolving understanding of the role of anti-leukocyte antibodies. Vox Sanguinis 83(Suppl 1): 299-303
Chitnavis, D.; Durrant, J.; Mahy, N.; Murphy, M.F. 2001: Transfusion-associated graft-versus-host disease after the transfusion of leucocyte-depleted red cells. British Journal of Haematology 113(Suppl 1): 55
Feinstone, S.M.; Kapikian, A.Z.; Purcell, R.H.; Alter, H.J.; Holland, P.V. 1975: Transfusion-associated hepatitis not due to viral hepatitis type A or B. New England Journal of Medicine 292(15): 767-770
Sun, C.F. C.; Hsieh, Y.Y.; Ngan, K.W.; Wang, W.T. 2000: Transfusion-induced immunomodulation in gastric cancer patients after operation. Annals of Clinical and Laboratory Science 30(3): 317
Uhrynowska, M.; Szczepanik, A.B.; Konopka, L.; Seferynska, I.; Zupanska, B. 2003: Transfusion-related acute lung injury Diagnostic problems. Acta Haematologica Polonica 34(4): 507-512
Mariano, M.; Miceli, P.; Roncaglia, R.; Baraldi, A.; De Palma, M. 2000: Transfusion-related acute lung injury during plasma exchange with cryodepleted FFP. Vox Sanguinis 78(Suppl 1): P073
Mani, A.; Rawat, P.; Kakkar, N.; Brown, C.; Britt, R.P. 2003: Transfusion-related acute lung injury in North India from a donor related by marriage. Vox Sanguinis 84(2): 140
Leger, R.; Palm, S.; Wulf, H.; Vosberg, A.; Neppert, J. 1999: Transfusion-related lung injury with leukopenic reaction caused by fresh frozen plasma containing anti-NB1. Anesthesiology 91(5): 1529-1532
Mynster, T.; Christensen, I.J.; Nielsen, H.J. 1999: Transfusion-related postoperative infections and survival after elective colorectal cancer surgery. Gastroenterology 116(4 Part 2): A1336
Tasaki, T.; Satoh, S.; Gotoh, K.; Itoh, C.; Ono, Y.; Ishida, Y.; Kuriya, S. 2000: Transfusion-related problems in a patient with donor ABO-type red cells one year after major ABO-mismatched bone marrow transplantation. Vox Sanguinis 78(Suppl 1): P627
Hillyer, C.D.; Roback, J.D.; Saakadze, N.; Lezhava, L.; Hillyer, W.M.; Maiers, T.; Newman, J.L. 2003: Transfusion-transmitted cytomegalovirus infection Elucidation of role and dose of monocytes in a murine model. Blood 102(11): 57a
Claise, C.; Mendel, I.; Plouvier, E.; Godin, M.; Glikmanas, M.; Gatineau Sailliant, G.; Morel, A.; Buffet Janvresse, C.; Thuillier, F.; Bogard, M. 1999: Transfusion-transmitted virus in French patients with chronic hepatitis C. Abstracts of the General Meeting of the American Society for Microbiology 99: 167
Usta, M.; Dilek, K.; Ersoy, A.; Mistik, R.; Heper, Y.; Gullulu, M.; Yavuz, M.; Oktay, B.; Yurtkuran, M. 2002: Transfusion-transmitted virus infection in renal transplant recipients. Transplantation Proceedings 34(8): 3209-3210
Cappellini, M.D. 1999: Transfusional iron overload The thalassaemias. European Journal of Clinical Investigation 29(Suppl 1): 65
Fedorovskaya, Y.A.; Khanes, G.A.; Nazarchuck, L.V. 2000: Transfusional provision of newborns with surgical sepsis in chernobyl zone. Vox Sanguinis 78(Suppl 1): P647
Yenice, N.; Gokden, Y.; Erdem, L.; Turkmen, S.; Arican, N. 2004: Transfusional transmitted virus seroprevalence in asymptomatic HBsAg (+) hepatitis B carriers. Scandinavian Journal of Gastroenterology 39(2): 174-177
Mullon, J.; Giacoppe, G.; Clagett, C.; McCune, D.; Dillard, T. 2000: Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. New England Journal of Medicine 342(22): 1638-1643
Schimke, P.A.; Williams, J.L.; Melendez, M.; Destrempes, M.M.; Bombard, M.; Woodis, S.; Woodis, H.; Blash, S.; Gavin, W.G.; Ziomek, C.A.; Meade, H.M.; Echelard, Y. 2001: Transgene chimerism observed in a F2 goat. Theriogenology 55(1): 526
Jong, M.C.; Zhu, Y.; Frazer, K.A.; Gong, E.L.; Krauss, R.M.; Zhang, J.; Cheng, J.F.; Rubin, E.M. 1999: Transgene complementation of a 450 kb targeted deletion identifies OCTN2 as a modulator of triglyceride production. Circulation 100(18): 1; 610
Birchler, J.A.; Pal Bhadra, M.; Bhadra, U. 2003: Transgene cosuppression in animals. Hannon, Gregory J , Reprint Author RNAi: A guide to gene silencing: 23-42
Tresco, P.; Messina, D.; Jorgensen, C.M.; Krueger, G.G. 2000: Transgene expression by and survival of genetically modified human fibroblasts in an encapsulated cell delivery in the subcutaneous space of athymic mice. Journal of Investigative Dermatology 114(4): 825
Petersen, M.; Jorgensen, C.; Tandeski, T.; Chen, M.; Morgan, J.; Krueger, G. 2002: Transgene expression by human fibroblasts in vivo is under hierarchical regulation. Journal of Investigative Dermatology 119(1): 268
Kuliszewski, M.A.; Sandhu, R.; Kutryk, M.J.B.; Fitchett, D.H.; Stewart, D.J. 2000: Transgene expression following passage of plasmid DNA through the NOGA needle injection catheter Effect of injection pressure. Canadian Journal of Cardiology 16(Suppl F): 156F
Eastman, S.J.; Chu, Q.; Tousignant, J.D.; Cheng, S.H.; Scheule, R.K. 2002: Transgene expression in polarized cells. Official Gazette of the United States Patent and Trademark Office Patents 1263(3)
Nakamura, M.; Takase, M.; Yuge, M. 2001: Transgene expression in the ovary of the frog. Biology of Reproduction 64(Suppl 1): 296
Zermansky, A.J.; Lowenstein, P.R.; Castro, M.G. 2000: Transgene expression in the substantia nigra following intra-striatal delivery of recombinant adenovirus is dependent on the transgene. European Journal of Neuroscience 12(Suppl 11): 308
Pang, J.; Wang, X.; Ott, S.; Appukuttan, B.; Patel, R.; Cheng, M.; Runstadler, H.; Blanks, J.C.; Stout, J.T. 2000: Transgene expression of lentivirus-mediated beta-subunit of rod cGMP phosphodiesterase in human ocular cells. IOVS Investigative Ophthalmology and Visual Science 41(4): S395
Nakauchi, S.; Kawada, T.; Nakatsuru, Y.; Nakazawa, M.; Hemmi, C.; Masui, F.; Shin, W.S.; Kudo, Y.; Toyo Oka, T. 2001: Transgene expression other than target organ in gene therapy. Japanese Journal of Pharmacology 85(Suppl 1): 191P
Armentano, D.; Marshall, J.; Yew, N.S.; Cheng, S.H.; Gregory, R.J. 1999: Transgene expression system for increased persistence. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)
Kaplan, J.; Armentano, D.; Gregory, R.J. 2000: Transgene expression systems. Official Gazette of the United States Patent and Trademark Office Patents 1237(2)
Kumar, S.; Fladung, M. 2000: Transgene integration and T-DNA repeat formation in transgenic aspen. Plant Biology (Rockville) : 139
Bilodeau, A.S.; Lazaris, A.; Zhou, J.F.; Leduc, M.; Gauthier, M.; Mellor, S.; Kafidi, N.; Baldassarre, H.; Wang, B.; Karatzas, C.N. 2001: Transgene localization and integration site analysis in a betacasein-human tissue plasminogen activator BELE goat line by FISH. Annales de Genetique 44(Suppl 1): s41
Monroe, J.J.; Kort, K.L.; Marino, D.R.; Skopek, T.R. 1999: Transgene methylation and in vivo spontaneous mutation frequency. Environmental and Molecular Mutagenesis 33(Suppl 33): 45
Yang, J.; Ratovitski, T.; Brady, J.P.; Solomon, M.B.; Wells, K.D.; Pursel, V.G.; Wall, R.J. 2002: Transgene of myostatin pro domain dramatically increases muscle development and carcass weight in mice. Transgenic Research 11(1): 89
Gambino, G.; Perrone, I.; Carra, A.; Chitarra, W.; Boccacci, P.; Torello Marinoni, D.; Barberis, M.; Maghuly, F.; Laimer, M.; Gribaudo, I. 2010: Transgene silencing in grapevines transformed with GFLV resistance genes: analysis of variable expression of transgene, si RNAs production and cytosine methylation. Transgenic Research 19(1): 17-27
Pierce, M.L.; Essenberg, M.; Chen, Y.S.; Patil, M.A. 1999: Transgene suppression of terpenoid defense compound biosynthesis in cotton. Phytopathology 89(6 Suppl): S60
Wang, X.; Maddaloni, M.; Hoyt, T.; Riccardi, C.; Hone, D.M.; Pascual, D.W. 2003: Transgene vaccination against HIV-1 env using UEA-1-mediated delivery. FASEB Journal 17(7): C323
Bushman, J.; Ciavatta, D.; Smithies, O.; Kirby, S. 2004: Transgene-Induced Enhancement of Hemato-Vascular Differentiation from Murine Embryonic Stem Cells. FASEB Journal 18(4-5): Abstract 144
Scherer, S.S.; Bone, L.J.; Messing, A.; Willecke, K.; Fischbeck, K.; Xu, X.T. 1999: Transgene-restricted expression of connexin32 to myelinating Schwann cells prevents demyelination in connexin32-null mice. Society for Neuroscience Abstracts 25(1-2): 482
Lesnikova, M.; Bukovsky, A.; Morris, J.; Thompson, J.; Kiem, H.P.; Storb, R.F.; Nash, R.A.; Georges, G.E. 2003: Transgene-specific T cell responses to canine dendritic cells transduced by an RD114-pseudotype oncoretroviral vector compared to a VSV-G-pseudotype lentiviral vector. Blood 102(11): 748a
Martin, C.; Plat, M.; Terqui, M.; Conde, F.; Melchior, B.; Coulon, F.; Nerriere Daguin, V.; Neveu, I.; Naveilhan, P.; Soulillou, J.P.; Vanhove, B.; Brachet, P. 2003: Transgeneic pigs expressing CTLA4-Ig in neurons and xenotransplantation for brain repair. Xenotransplantation 10(5): 492
Anway, M.D.; Uzumcu, M.; Memon, M.A.; Skinner, M.K. 2004: Transgenerational effects from embryonic exposure to anti-androgen endocrine disrupter vinclozolin in adult male rats. Journal of Andrology Suppl (Suppl): 40
Valencia, A.M.; Beharry, K.D.A.; Abrantes, M.S.; Elrify, E.S.; Hartleroad, J.Y.; Akmal, A.; Modanlou, H.D. 2003: Transgenerational effects of antenatal betamethasone on lung weight and lung matrix metalloproteinases in the rat. Pediatric Research 53(4 Part 2): 416A-417A
Gray, L.E.; Barlow, N.J.; Furr, J.R.; Brock, J.; Silva, M.J.; Barr, D.B.; Ostby, J.S. 2003: Transgenerational effects of di phthalate in the male rat. Toxicological Sciences 72(S-1): 283
Baulch, J.E.; Raabe, O.G.; Overstreet, J.W. 2003: Transgenerational effects of paternal exposure to ionizing radiation. Environmental and Molecular Mutagenesis 41(3): 164
Stouder, C.; Paoloni-Giacobino, A. 2010: Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm. Reproduction 139(2): 373-379
Szyf, M.; Weaver, I.C.G.; Cervoni, N.; D'alessio, A.C.; Champagne, F.A.; Meaney, M.J. 2003: Transgenerational epigenomic imprinting by maternal behavior through DNA methylation and its reversal by histone deacetylase inhibitors. American Journal of Medical Genetics 122B(1): 13
Peterson, B.N.; Foran, C.M.; Benson, W.H. 2002: Transgenerational ethynylestradiol exposure Reproductive and physiological effects. Marine Environmental Research 54(3-5): 753-754
Abrantes, M.S.; Beharry, K.D.A.; Valencia, A.M.; Elrify, E.S.; Akmal, A.; Hartleroad, J.Y.; Modanlou, H.D. 2003: Transgenerational imprinting effects of antenatal betamethasone Influence on weight, linear growth, glucose, insulin, insulin-like growth factor-I, growth hormone and leptin in the rat. Pediatric Research 53(4 Part 2): 369A
Collins, J.W.Jr; David, R.J.; Wu, S.Y.en 2000: Transgenerational increase in infant birthweight occurs among White but not African-American and Mexican-American immigrant families in Illinois A population-based study. American Journal of Epidemiology 151(11 Suppl): S12
Furitsu, K.; Ryo, H.; Elisseeva, K.; Fukudome, Y.; Krupnova, E.; Smirnova, L.; Nakajima, H.; Nomura, T. 2003: Transgenerational mutations in the children of the liquidators who worked for the Chernobyl nuclear power plant accident. Journal of Radiation Research 44(4): 420
Wong, F.S.; Dittel, B.N.; Janeway, C.A. 1999: Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis. Immunological Reviews 169: 93-104
Sugaya, M.; Watanabe, T.; Atkins, A.; Aquilino, E.; Borris, D.; Jaffe, E.; Feigenbaum, L.; Blauvelt, A. 2002: Transgenes expressed under the control of the VEGFR-3 promoter are selectively expressed by lymphatic endothelial cells of transgenic mice. Journal of Investigative Dermatology 119(1): 209
Harman, G.E. 2000: Transgenes from biocontrol microbes for the production of plants resistant to fungal diseases. Phytopathology 90(6 Suppl): S109
Mitra, A.; Ma, C. 2002: Transgenes with direct repeats induce high frequency cosuppression. Plant Biology (Rockville) : 62
Kuliyev, E.; Hamlet, M.J.; Doherty, J.R.; Zhu, H.; Yergeau, D.A.; Mead, P.E. 2003: Transgenesis and insertional mutagenesis in Xenopus. Developmental Biology 259(2): 540
Campbell, Keith, H.S. 2002: Transgenesis and nuclear transfer, progress in gene additions and knockouts. Cloning and Stem Cells 4(3): 280
Furlow, J.D. 2002: Transgenesis in the frog Xenopus laevis Recent advances and potential applications. Transgenic Research 11(1): 78-79
Mullins, L.J.; Brooker, G.; Mullins, J.J. 2002: Transgenesis in the rat. Methods in Molecular Biology 180: 255-270
Shim, S.W.; Kim, Y.H.; Jun, S.H.; Lim, J.M.; Chung, H.M.; Ko, J.J.; Lee, H.T.; Chung, K.S.; Shim, H. 2000: Transgenesis of porcine embryos using intracytoplasmic sperm injection. Theriogenology 53(1): 521
Scott, M.; Dearmond, S.J.; Prusiner, S.B.; Ridley, R.M.; Baker, H.F. 1999: Transgenetic investigations of the species barrier and prion strains. Prusiner, S B Cold Spring Harbor Monograph Series; Prion biology and diseases 307-347
Surani, A. 2002: Transgenetic mouse which comprises an inactive Peg3 gene, and the use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1262(2)
Szopa, J. 2002: Transgenic 14-3-3 isoforms in plants. Biochemical Society Transactions 30(3): A65
Regan, S.E.; Cerniway, R.J.; Broad, R.M.; Byford, A.M.; Matherne, G.P.ul 2002: Transgenic A1 adenosine receptor over-expression attenuates apoptosis associated with ischemia-reperfusion injury in mouse heart. Pediatric Research 51(4 Part 2): 35A-36A
Stell, A.R.; Jones, R.; Byford, A.M.; Matherne, G.P. 1999: Transgenic A1 adenosine receptor overexpression improves recovery during hypoxia-reoxygenation in mouse heart. FASEB Journal 13(5 Part 2): A762
Foster, B.; Kwon, E.; Hurwitz, A.; Allison, J.; Greenberg, N. 1999: Transgenic Adenocarcinoma of Mouse Prostate Its uses to test therapeutic approaches to prostate cancer. European Urology 36(5): 460-461
Kuehnle, A.R.; Chen, F.C.; Sugii, N.C. 2001: Transgenic Anthurium. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 3-15
Newbury, H.J.; Senior, I. 2001: Transgenic Antirrhinum. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 16-26
Lieman Hurwitz, J.; Rachmilevitch, S.; Mittler, R.; Kaplan, A. 2000: Transgenic Arabidopsis plants that express a cyanobacterial gene involved in HCO3- uptake exhibit a significantly higher photosynthetic rate, at limiting CO2 concentrations, than the wild type. Plant Biology (Rockville) : 160
Yu, W.; Schoelz, J.E. 2001: Transgenic Arabidopsis that expresses CaMV gene VI complements a CaMV isolate that contains a lethal mutation. Phytopathology 91(6 Suppl): S98
Nin, S.; Bennici, A. 2001: Transgenic Artemisia. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 27-42
Kiyokawa, S.; Kikuchi, Y.; Kamada, H.; Harada, H. 2001: Transgenic Begonia. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 43-54
Zhang, Z.; Song, Y.; Zhao, X.; Zhang, X.; Chen, Y. 2001: Transgenic Bmp4 rescues cleft palate in Msx1-deficient mice Role of BMP and SHH signaling in mammalian palate development. Development Growth and Differentiation 43(Suppl): S106
Enikeev, A.G.; Mishutina, U.O.; Mapelli, S.P.; Pacovsky, R.S.; Salyaev, R.K.; Rekoslavskaya, N.I.; Donskaya, L.I.; Musalevskaya, O.; Okolnikova, N.V. 2000: Transgenic Brassica napus L with the genes ugt and acb. Plant Physiology and Biochemistry (Paris) 38(Suppl): s94
FangXiaoPing; WangZhuAn; ChenRuMei; LiJun; FanYunLiu; LuoLiXia; ChenKunRong; RenLi 2010: Transgenic Brassica napus growing with phytate as a sole phosphorus source. Acta Agronomica Sinica: 2, 228-232
Peraus, G.; Hoppe, E.; Baumeister, R. 2004: Transgenic C elegans as a model organism for investigations on Alzheimers disease. Official Gazette of the United States Patent and Trademark Office Patents 1278(1)
Jongbloed, M.; Poelmann, R.E.; Schalij, M.J.; Fishman, G.I.; Gittenberger, D.G.oot, A.C. 2003: Transgenic CCS/lacZ expression in the pulmonary venous area in murine embryos; source of atrial arrhythmias?. European Heart Journal 24(Abstract Suppl): 380
Loveland, B.; Kyriakou, P.; Kahn, D.; Van Rensberg, M.; Mckenzie, I. 2001: Transgenic CD46 prevents hyperacute rejection of pig kidney xenografts in baboons. Immunology and Cell Biology 79(4): A13-A14
Ishimaru, K.; Ando, M.; Takamiya, M.; Terahara, N.; Yamakawa, T.; Shimomura, K.; Tanaka, N. 2001: Transgenic Campanula spp. Bajaj, Y P S Biotechnology in Agriculture and Forestry Transgenic crops III 55-69
Cohill, P.R.; Cannons, A.C. 2001: Transgenic Chlorella as a phytoremedial bioreactor. FASEB Journal 15(5): A877
D.Jong, J. 2001: Transgenic Dendranthema. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 84-94
Chia, T.F.; Lim, A.Y.H.; Luan, Y.; Ng, I. 2001: Transgenic Dendrobium. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 95-106
Zuker, A.; Tzfira, T.; Ahroni, A.; Shklarman, E.; Ovadis, M.; Itzhaki, H.; Ben Meir, H.; Vainstein, A. 2001: Transgenic Dianthus spp. Bajaj, Y P S Biotechnology in Agriculture and Forestry Transgenic crops III 70-83
Handa, T.; Deroles, S.C. 2001: Transgenic Eustoma grandiflorum. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 107-122
Toki, T.; Katsuoka, F.; Kanezaki, R.; Kamio, T.; Tandai, S.; Kurotaki, H.; Yagihashi, S.; Igarashi, K.; Yamamoto, M.; Ito, E. 2002: Transgenic Expression of BACH1 Results in Megakaryocytic Linage Impairement. Blood 100(11): Abstract No. 2843
Pavelko, K.D.; Rodriguez, M. 2004: Transgenic Expression of Known Antigenic Determinants of Theiler39;s Murine Encephalomyelitis Virus. FASEB Journal 18(4-5): Abstract 335
Furbank, R.T.; Chitty, J.A.; Taylor, W.C. 2001: Transgenic Flaveria bidentis. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 319-336
Heilig, C.W.; Saunders, T.; Moley, K. 2002: Transgenic GLUT1-deficient embryos exhibit impaired glucose uptake and apoptisis, leading to developmental delay and malformations resembling diabetic embryopathy. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 298A
Momcilovic, I.; Grubisic, D.; Neskovic, M. 2001: Transgenic Gentiana species. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 123-138
Elomaa, P.; Teeri, T.H. 2001: Transgenic Gerbera. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 139-154
Kamo, K.; Roh, M.; Blowers, A.; Smith, F.; Van Eck, J. 2001: Transgenic Gladiolus. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 155-170
Sevon, N.; Biondi, S.; Bagni, N.; Oksman Caldentey, K.M. 2001: Transgenic Hyoscyamus muticus. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 171-200
Ishimaru, K.; Murakami, Y.; Shimomura, K. 2001: Transgenic Hyssopus officinalis. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 201-208
Brodie, C.R.; Fairbanks, C.A.; Boland, L.M.; Wilcox, G.L.; Orr, H.T. 1999: Transgenic ICER mice show decreased corneal nociception. Society for Neuroscience Abstracts 25(1-2): 421
Hook, I.L.I.; Sheridan, H. 2001: Transgenic Leontopodium. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 221-236
Sukhai, M.A.; Wu, X.; Xuan, Y.; Dube, K.; Rego, E.; Bhaumik, M.; Wells, R.A.; Kamel Reid, S.; Pandolfi, P.P.olo 2002: Transgenic Mice Expressing hCG-NuMA-RARalpha Develop Hematopoietic Abnormalities Leading to Acute Promyelocytic Leukemia. Blood 100(11): Abstract No. 2097
Toriyama, K.; Tanabe, M.; Rashid, H. 2001: Transgenic Moricandia. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 352-358
Zapata, J.M.; Pedersen, I.M.; Krajewska, M.; Thomas, M.; Reed, J.C. 2002: Transgenic Mouse Models of Low-Grade B-Cell Lymphoma. Blood 100(11): Abstract No. 751
Pedersen, I.M.; Zapata, J.M.; Sporn, M.; Carson, D.A.; Leoni, L.M.; Reed, J.C. 2002: Transgenic Mouse Models of Lymphoma for Preclinical Analysis of Novel Anti-Cancer Drugs. Blood 100(11): Abstract No. 1365
Godo, T.; Mii, M. 2001: Transgenic Nierembergia scoparia. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 237-248
Rubio, M.; Bodi, I.; Koch, S.; Schwartz, A. 2004: Transgenic Overexpression of the Human L-type Calcium Channel Results in Changes in the Auxiliary Subunits during Heart Failure. FASEB Journal 18(4-5): Abstract 641
Anzai, H.; Tanaka, M. 2001: Transgenic Phalaenopsis. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 249-264
Faria, J.C.; Cancado, L.J.; Albino, M.M.C.; Dias, B.B.A.; Vianna, M.G.R.; Rech, E.L.; Maxwell, D.P.; Aragao, F.J.L. 2000: Transgenic Phaseolus vulgaris engineered with a mutant rep gene had resistance to Bean golden mosaic geminivirus. Phytopathology 90(6 Suppl): S23
Blum, H.E. 2002: Transgenic Plants Principle and medical applications. Deutsche Medizinische Wochenschrift 127(46): 2451-2454; 15 November
Kocken, C.H.M.; Beetsma, A.L.; Van Der Wel, A.M.; Van Gemert, G.J.; Eling, W.; Ozwara, H.; Thomas, A.W. 2003: Transgenic Plasmodium knowlesi to investigate vaccine and drug targets at the molecular level. Experimental Parasitology 105(1): 50-51
Zhuang, S.Z.; Li, X.J.; Zhang, A.L.; Ma, J.; Zheng, Y.H.; Zhang, F.C. 2010: Transgenic RNAi-mediated reduction of LZP3 in Lagurus lagurus oocytes results in decreased fertilization ability in IVF. Molecular Biology Reports 37(3): 1253-1259
Daimon, H.; Mii, M. 2001: Transgenic Rudbeckia. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 265-273
Dubey, T.; Guerra, D.J. 2000: Transgenic Russet Burbank potato resistant to late blight. Phytopathology 90(6 Suppl): S20
Bains, R.K.; Flavell, D.M.; Le Tissier, P.R.; Wells, S.E.; Bennett, P.A.; Stoye, J.P.; Robinson, I.C.A.F. 2000: Transgenic SLOB rats showing Severe Late-onset male-specific visceral obesity. Journal of Endocrinology 164(Suppl ): P201
Moravcikova, J.; Bekesiova, I.; Libantova, J.; Nap, J.P.; Mlynarova, L'udmila 1999: Transgenic Slovak potato cultivars carrying the basic tobacco beta-1,3-glucanase and the acidic cucumber chitinase. Biologia 54(Suppl 7): 51-52
Liu, T.H.A.; Stephens, L.C.; Hannapel, D.J. 2001: Transgenic Solanum brevidens. Bajaj, Y P S Author Biotechnology in Agriculture and Forestry Transgenic crops III 359-371
Edelman, M.; Vunsh, R.; Li, J.; Hanania, U.; Flaishman, M.; Vishnevetsky, J.; Perl, A. 2003: Transgenic Spirodela A unique, low-risk, plant biotechnology system. In Vitro Cellular and Developmental Biology. Plant 39: 21A
Bai, X.F.; Liu, J.Q.; Li, O.; Zheng, P.; Liu, Y. 2002: Transgenic T cell-therapy of large tumors selects for antigenic variants in vivo. FASEB Journal 16(4): A664
Velidedeoglu, E.; Jarret, B.; Lee, K.; Moore, D.; Huang, X.; Deng, S.; Lian, M.M.; Caton, A.; Markmann, J.F. 2002: Transgenic T cells persist in an adoptive transfer model of mouse liver transplantation tolerance. Transplantation Proceedings 34(8): 3342-3344
Meng, X.; Sawamura, D.; Baba, T.; Ina, S.; Ita, K.; Tamai, K.; Hanada, K.; Hashimoto, I. 1999: Transgenic TNF-alpha causes apoptosis in epidermal keratinocytes after subcutaneous injection of TNF-alpha DNA plasmid. Journal of Investigative Dermatology 113(5): 856-857
Dithmar, S.; Kramer, T.R.; Grossniklaus, H.E. 2001: Transgenic TPras cell lines in a murine model for metastatic ocular melanoma. IOVS Investigative Ophthalmology and Visual Science 42(4): S218
Mukundan, U.; Hjortso, M. 2001: Transgenic Tagetes spp. Bajaj, Y P S Biotechnology in Agriculture and Forestry Transgenic crops III 274-293
Aida, R.; Shibata, M. 2001: Transgenic Torenia fournieri Lind. Bajaj, Y P S Biotechnology in Agriculture and Forestry Transgenic crops III 294-305
Carrillo, C.; Cejas, S.; Gonzalez, N.S.; Algranati, I.D. 2000: Transgenic Trypanosoma cruzi Transformation with C fasciculata ODC gene Expression and characterization of the foreign product. Memorias do Instituto Oswaldo Cruz 95(Suppl 2): 287
Lowell, B.B.; Zhang, C.Y.; Chan, C.B.; Wheeler, M.B. 2002: Transgenic UCP2 knockout mouse and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1257(1)
Kunstfeld, R.; Hirakawa, S.; Lin, C.; Velasco, P.; Schacht, V.; Wei, X.; Detmar, M. 2003: Transgenic VEGF overexpression induces enlargement of cutaneous lymphatic vessels that is further enhanced by delayed-type hypersensitivity reactions. Journal of Investigative Dermatology 121(1): 0023
Kunstfeld, R.; Hirakawa, S.; Lin, C.; Velasco, P.; Schacht, V.; Detmar, M. 2003: Transgenic VEGF-A induces enlargement of lymphatic vessels in normal and inflamed skin. Inflammation Research 52(Suppl 2): S 107
Wagner, K.D.; Wagner, N.; Vidal, V.; Wilhelm, D.; Schedl, A.; Englert, C.; Scholz, H. 2001: Transgenic YAC-complementation reveals a requirement of the Wilms tumor gene, WT1, for retinal development. Pfluegers Archiv European Journal of Physiology 441(6 Suppl): R109
Baines, C.P.; Zhang, J.; Zheng, Y.T.; Xiu, J.X.; Bolli, R.; Ping, P. 2001: Transgenic activation of PKCepsilon preferentially increases mitochondrial PKCepsilon expression and enhances formation of a mitochondrial PKCepsilon-JNK signaling complex in the mouse heart. FASEB Journal 15(4): A103
Noutsias, M.; Tschoepe, C.; Koeniger, J.; Spillmann, F.; Escher, F.; Westermann, D.; Cumalioglu, Y.; Bader, M.; Schultheiss, H.P. 2001: Transgenic activation of the kallikrein-kinin system prevents streptozotocin-diabetic hearts from cardiac fibrosis and left ventricular dysfunction. European Heart Journal 22(Abstract Suppl): 54
Noutsias, M.; Tschoepe, C.; Escher, F.; Koeniger, J.; Spillmann, F.; Scheeler, M.; Walther, T.; Schultheiss, H.P.; Bader, M. 2001: Transgenic activation of the kallikrein-kinin system reduces intramyocardial expression of TNFa and II-1b and improves left ventricular function in experimental diabetic cardiopathy. European Heart Journal 22(Abstract Suppl): 680
Yuge, M.; Levine, E.; Amaya, E.; Souich, O.; Cho, K.W.Y. 2001: Transgenic analyses of the Xenopus goosecoid regulatory elements during the organizer formation. Development Growth and Differentiation 43(Suppl): S43
Irvine, S.Q.; Ruddle, F.H. 2003: Transgenic analysis of genomic regulation of the Dll-B gene in the ascidian Ciona intestinalis. Developmental Biology 259(2): 468
Denton, C.P.; Abraham, D.J. 2004: Transgenic analysis of scleroderma: understanding key pathogenic events in vivo. Autoimmunity Reviews 3(4): 285-293
Bacon, A.; Holmes, F.E.; Wynick, D. 1999: Transgenic analysis of the axotomy response elements of the murine galanin gene. Society for Neuroscience Abstracts 25(1-2): 1040
White, J.K.; Papo, N.; Blackwell, J.M. 2000: Transgenic analysis of the effect of human NRAMP1 on resistance to infection and autoimmunity. Immunology 101(Suppl 1): 97
Low, M.J.; Rubinstein, M.; Chan, E.C.eng 2001: Transgenic analysis of the proopiomelanocortin neuroendocrine system. Matzuk, Martin M, Brown, Chester W, Kumar, T Rajendra Contemporary Endocrinology Transgenics in endocrinology 319-337
Miller Bertoglio, V.; Halpern, M.E. 2000: Transgenic analysis of the zebrafish chordin promoter. Developmental Biology 222(1): 278
Soreq, H.; Cohen, O.; Meshorer, E.; Ginzberg, D.; Glick, D.; Yirmiya, R. 2002: Transgenic and antisense manipulations of impairments in cholinergic balance. Journal of Neurochemistry 81(Suppl 1): 41
Chi, X.; Demayo, F.J.; Schwartz, R.J. 2003: Transgenic and comparative genomic analysis revealed novel long-range regulation of Nkx2-5 in mouse development. Developmental Biology 259(2): 465